<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Ann Clin Transl Neurol</journal-id>
<journal-id journal-id-type="iso-abbrev">Ann Clin Transl Neurol</journal-id>
<journal-id journal-id-type="doi">10.1002/(ISSN)2328-9503</journal-id>
<journal-id journal-id-type="publisher-id">ACN3</journal-id>
<journal-title-group>
<journal-title>Annals of Clinical and Translational Neurology</journal-title>
</journal-title-group>
<issn pub-type="epub">2328-9503</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29761117</article-id>
<article-id pub-id-type="pmc">5945967</article-id>
<article-id pub-id-type="doi">10.1002/acn3.551</article-id>
<article-id pub-id-type="publisher-id">ACN3551</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Research Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Genomic analysis identifies masqueraders of full‐term cerebral palsy</article-title>
<alt-title alt-title-type="left-running-head">Y. Takezawa <italic>et al</italic>.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="acn3551-cr-0001">
<name>
<surname>Takezawa</surname>
<given-names>Yusuke</given-names>
</name>
<xref ref-type="aff" rid="acn3551-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="acn3551-cr-0002">
<name>
<surname>Kikuchi</surname>
<given-names>Atsuo</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1002-8739</contrib-id>
<address>
<email>akikuchi-thk@umin.ac.jp</email>
</address>
<xref ref-type="aff" rid="acn3551-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="acn3551-cr-0003">
<name>
<surname>Haginoya</surname>
<given-names>Kazuhiro</given-names>
</name>
<address>
<email>khaginoya@kha.biglobe.ne.jp</email>
</address>
<xref ref-type="aff" rid="acn3551-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="acn3551-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="acn3551-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3551-cr-0004">
<name>
<surname>Niihori</surname>
<given-names>Tetsuya</given-names>
</name>
<xref ref-type="aff" rid="acn3551-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3551-cr-0005">
<name>
<surname>Numata‐Uematsu</surname>
<given-names>Yurika</given-names>
</name>
<xref ref-type="aff" rid="acn3551-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="acn3551-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3551-cr-0006">
<name>
<surname>Inui</surname>
<given-names>Takehiko</given-names>
</name>
<xref ref-type="aff" rid="acn3551-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="acn3551-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3551-cr-0007">
<name>
<surname>Yamamura‐Suzuki</surname>
<given-names>Saeko</given-names>
</name>
<xref ref-type="aff" rid="acn3551-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3551-cr-0008">
<name>
<surname>Miyabayashi</surname>
<given-names>Takuya</given-names>
</name>
<xref ref-type="aff" rid="acn3551-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3551-cr-0009">
<name>
<surname>Anzai</surname>
<given-names>Mai</given-names>
</name>
<xref ref-type="aff" rid="acn3551-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="acn3551-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3551-cr-0010">
<name>
<surname>Suzuki‐Muromoto</surname>
<given-names>Sato</given-names>
</name>
<xref ref-type="aff" rid="acn3551-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3551-cr-0011">
<name>
<surname>Okubo</surname>
<given-names>Yukimune</given-names>
</name>
<xref ref-type="aff" rid="acn3551-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="acn3551-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3551-cr-0012">
<name>
<surname>Endo</surname>
<given-names>Wakaba</given-names>
</name>
<xref ref-type="aff" rid="acn3551-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="acn3551-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3551-cr-0013">
<name>
<surname>Togashi</surname>
<given-names>Noriko</given-names>
</name>
<xref ref-type="aff" rid="acn3551-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3551-cr-0014">
<name>
<surname>Kobayashi</surname>
<given-names>Yasuko</given-names>
</name>
<xref ref-type="aff" rid="acn3551-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3551-cr-0015">
<name>
<surname>Onuma</surname>
<given-names>Akira</given-names>
</name>
<xref ref-type="aff" rid="acn3551-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3551-cr-0016">
<name>
<surname>Funayama</surname>
<given-names>Ryo</given-names>
</name>
<xref ref-type="aff" rid="acn3551-aff-0005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3551-cr-0017">
<name>
<surname>Shirota</surname>
<given-names>Matsuyuki</given-names>
</name>
<xref ref-type="aff" rid="acn3551-aff-0006">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3551-cr-0018">
<name>
<surname>Nakayama</surname>
<given-names>Keiko</given-names>
</name>
<xref ref-type="aff" rid="acn3551-aff-0005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3551-cr-0019">
<name>
<surname>Aoki</surname>
<given-names>Yoko</given-names>
</name>
<xref ref-type="aff" rid="acn3551-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3551-cr-0020">
<name>
<surname>Kure</surname>
<given-names>Shigeo</given-names>
</name>
<xref ref-type="aff" rid="acn3551-aff-0001">
<sup>1</sup>
</xref>
</contrib>
</contrib-group>
<aff id="acn3551-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Pediatrics</named-content>
<institution>Tohoku University School of Medicine</institution>
<named-content content-type="street">2‐1 Seiryo‐machi, Aoba‐ku</named-content>
<named-content content-type="city">Sendai</named-content>
<named-content content-type="country-part">Miyagi</named-content>
<named-content content-type="post-code">980‐8575</named-content>
<country country="JP">Japan</country>
</aff>
<aff id="acn3551-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Pediatric Neurology</named-content>
<institution>Miyagi Children's Hospital</institution>
<named-content content-type="street">4‐3‐17, Ochiai, Aoba‐ku</named-content>
<named-content content-type="city">Sendai</named-content>
<named-content content-type="country-part">Miyagi</named-content>
<named-content content-type="post-code">989‐3126</named-content>
<country country="JP">Japan</country>
</aff>
<aff id="acn3551-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Department of Pediatric Neurology</named-content>
<institution>Takuto Rehabilitation Center for Children</institution>
<named-content content-type="city">Sendai</named-content>
<named-content content-type="post-code">982‐0241</named-content>
<country country="JP">Japan</country>
</aff>
<aff id="acn3551-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Department of Medical Genetics</named-content>
<institution>Tohoku University School of Medicine</institution>
<named-content content-type="street">2‐1 Seiryo‐machi, Aoba‐ku</named-content>
<named-content content-type="city">Sendai</named-content>
<named-content content-type="country-part">Miyagi</named-content>
<named-content content-type="post-code">980‐8575</named-content>
<country country="JP">Japan</country>
</aff>
<aff id="acn3551-aff-0005">
<label><sup>5</sup></label>
<named-content content-type="organisation-division">Division of Cell Proliferation</named-content>
<named-content content-type="organisation-division">United Centers for Advanced Research and Translational Medicine</named-content>
<institution>Tohoku University Graduate School of Medicine</institution>
<named-content content-type="street">2‐1 Seiryo‐machi, Aoba‐ku</named-content>
<named-content content-type="city">Sendai</named-content>
<named-content content-type="post-code">980‐8575</named-content>
<country country="JP">Japan</country>
</aff>
<aff id="acn3551-aff-0006">
<label><sup>6</sup></label>
<named-content content-type="organisation-division">Division of Interdisciplinary Medical Sciences</named-content>
<institution>United Centers for Advanced Research and Translational Medicine</institution>
<institution>Tohoku University Graduate School of Medicine</institution>
<named-content content-type="street">2‐1 Seiryo‐machi, Aoba‐ku</named-content>
<named-content content-type="city">Sendai</named-content>
<named-content content-type="post-code">980‐8575</named-content>
<country country="JP">Japan</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break></break>
Kazuhiro Haginoya, Department of Pediatric Neurology, Miyagi Children's Hospital, 4‐3‐17, Ochiai, Aoba‐ku, Sendai, Miyagi 989‐3126, Japan. Tel:+81‐22‐391‐5111; Fax: +81‐22 ‐391‐5118; E‐mail: <email>khaginoya@kha.biglobe.ne.jp</email><break></break>
or<break></break>
Atsuo Kikuchi, Department of Pediatrics, Tohoku University School of Medicine, 2‐1 Seiryo‐machi, Aoba‐ku, Sendai, Miyagi 980‐8574, Japan. Tel: +81‐22‐717‐7287; Fax: +81‐22 ‐717‐7290; E‐mail: <email>akikuchi-thk@umin.ac.jp</email><break></break></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>26</day>
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<month>5</month>
<year>2018</year>
</pub-date>
<volume>5</volume>
<issue>5</issue>
<issue-id pub-id-type="doi">10.1002/acn3.2018.5.issue-5</issue-id>
<fpage>538</fpage>
<lpage>551</lpage>
<history>
<date date-type="received">
<day>27</day>
<month>11</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>14</day>
<month>2</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>2</month>
<year>2018</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2018 American Neurological Association <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2018 The Authors. <italic>Annals of Clinical and Translational Neurology</italic> published by Wiley Periodicals, Inc on behalf of American Neurological Association.</copyright-statement>
<license license-type="creativeCommonsBy-nc-nd">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:ACN3-5-538.pdf" xlink:type="simple"></self-uri>
<abstract id="acn3551-abs-0001">
<title>Abstract</title>
<sec id="acn3551-sec-0001">
<title>Objective</title>
<p>Cerebral palsy is a common, heterogeneous neurodevelopmental disorder that causes movement and postural disabilities. Recent studies have suggested genetic diseases can be misdiagnosed as cerebral palsy. We hypothesized that two simple criteria, that is, full‐term births and nonspecific brain <styled-content style="fixed-case">MRI</styled-content> findings, are keys to extracting masqueraders among cerebral palsy cases due to the following: (1) preterm infants are susceptible to multiple environmental factors and therefore demonstrate an increased risk of cerebral palsy and (2) brain <styled-content style="fixed-case">MRI</styled-content> assessment is essential for excluding environmental causes and other particular disorders.</p>
</sec>
<sec id="acn3551-sec-0002">
<title>Methods</title>
<p>A total of 107 patients—all full‐term births—without specific findings on brain <styled-content style="fixed-case">MRI</styled-content> were identified among 897 patients diagnosed with cerebral palsy who were followed at our center. <styled-content style="fixed-case">DNA</styled-content> samples were available for 17 of the 107 cases for trio whole‐exome sequencing and array comparative genomic hybridization. We prioritized variants in genes known to be relevant in neurodevelopmental diseases and evaluated their pathogenicity according to the American College of Medical Genetics guidelines.</p>
</sec>
<sec id="acn3551-sec-0003">
<title>Results</title>
<p>Pathogenic/likely pathogenic candidate variants were identified in 9 of 17 cases (52.9%) within eight genes: <italic><styled-content style="fixed-case">CTNNB</styled-content>1</italic>,<italic><styled-content style="fixed-case">CYP</styled-content>2U1</italic>,<italic><styled-content style="fixed-case">SPAST</styled-content></italic>,<italic><styled-content style="fixed-case">GNAO</styled-content>1</italic>,<italic><styled-content style="fixed-case">CACNA</styled-content>1A</italic>,<italic><styled-content style="fixed-case">AMPD</styled-content>2</italic>,<italic><styled-content style="fixed-case">STXBP</styled-content>1</italic>, and <italic><styled-content style="fixed-case">SCN</styled-content>2A</italic>. Five identified variants had previously been reported. No pathogenic copy number variations were identified. The <italic><styled-content style="fixed-case">AMPD</styled-content>2</italic> missense variant and the splice‐site variants in <italic><styled-content style="fixed-case">CTNNB</styled-content>1</italic> and <italic><styled-content style="fixed-case">AMPD</styled-content>2</italic> were validated by in vitro functional experiments.</p>
</sec>
<sec id="acn3551-sec-0004">
<title>Interpretation</title>
<p>The high rate of detecting causative genetic variants (52.9%) suggests that patients diagnosed with cerebral palsy in full‐term births without specific <styled-content style="fixed-case">MRI</styled-content> findings may include genetic diseases masquerading as cerebral palsy.</p>
</sec>
</abstract>
<funding-group>
<award-group>
<funding-source>JSPS KAKENHI</funding-source>
<award-id>JP16K09983</award-id>
</award-group>
<award-group>
<funding-source>Japan Agency for Medical Research and Development</funding-source>
</award-group>
<funding-statement>This work was funded by <funding-source>JSPS KAKENHI</funding-source> grant <award-id>JP16K09983</award-id>; <funding-source>Japan Agency for Medical Research and Development</funding-source> grant . </funding-statement>
</funding-group>
<counts>
<fig-count count="5"></fig-count>
<table-count count="2"></table-count>
<page-count count="14"></page-count>
<word-count count="8194"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>acn3551</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>May 2018</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.3.8.2 mode:remove_FC converted:11.05.2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="acn3551-sec-0005">
<title>Introduction</title>
<p>Cerebral palsy (CP) is the most common physical disability in childhood and is defined as “a group of permanent disorders of the development of movement and posture, causing activity limitation, that are attributed to nonprogressive disturbances that occurred in the developing fetal or infant brain”.<xref ref-type="ref" rid="acn3551-bib-0001">1</xref> Both genetic and environmental factors contribute to the etiology of CP. Recent studies have suggested that a larger number of rare pathogenic genetic variants<xref ref-type="ref" rid="acn3551-bib-0002">2</xref> or pathogenic copy number variations (CNVs)<xref ref-type="ref" rid="acn3551-bib-0003">3</xref> contribute to CP than previously expected.<xref ref-type="ref" rid="acn3551-bib-0004">4</xref> This suggests that “masquerading” genetic diseases can be misdiagnosed as CP.<xref ref-type="ref" rid="acn3551-bib-0005">5</xref> To distinguish these masqueraders from CP is essential for delivering appropriate therapy, prognosis, and genetic counseling. However, there is lack of consensus as to which types of unexplained CP should undergo genetic investigation. A recent meta‐analysis showed that preterm (&lt;37 weeks) infants had a dramatically increased risk of CP,<xref ref-type="ref" rid="acn3551-bib-0006">6</xref> which suggests that full‐term CP may include more masqueraders than preterm CP. To our knowledge, no genetic studies have specifically focused on full‐term CP. In addition, brain MRI findings are essential for correctly assessing CP by excluding cases caused by apparent environmental factors or cases with other disorders<xref ref-type="ref" rid="acn3551-bib-0005">5</xref> (e.g., porencephaly with <italic>COL4A1</italic> variants<xref ref-type="ref" rid="acn3551-bib-0007">7</xref> and cerebral infarction with <italic>CBS</italic> variants<xref ref-type="ref" rid="acn3551-bib-0008">8</xref>) for which other diagnostic approaches could be used, such as metabolic screening and target sequencing.</p>
<p>In this study, we performed trio whole‐exome sequencing (WES) analysis and array comparative genomic hybridization (aCGH) analysis to identify genetic abnormality, focusing on a subgroup of CP patients isolated by two simple criteria, (1) gestational age of 37 weeks or more and (2) normal or nonspecific brain MRI findings.</p>
</sec>
<sec id="acn3551-sec-0006">
<title>Methods</title>
<sec id="acn3551-sec-0007">
<title>Participants</title>
<p>Eight hundred and ninety‐seven cases of cerebral palsy, including spastic CP (hemiplegia/diplegia/triplegia/quadriplegia), ataxic CP, dyskinetic CP, and mixed type CP, were followed at the Takuto Rehabilitation Center for Children, Sendai, Japan between September 1, 1990 and March 31, 2016, as previously reported.<xref ref-type="ref" rid="acn3551-bib-0009">9</xref> Of these cases, 107 families were also recruited for inclusion with at least one family member of the family diagnosed with CP, according to the following criteria: (1) diagnosis of CP without a definitive acquired cause, (2) gestational age of 37 weeks or more, (3) no brain MRI findings that can aid in the diagnosis. Among these cases, 17 patients with both parents were available for trio WES, and written consent was obtained from all individuals (Fig. <xref ref-type="fig" rid="acn3551-fig-0001">1</xref>). This study was approved by the ethics committee of Tohoku University Hospital and Takuto Rehabilitation Center for Children.</p>
<fig fig-type="Figure" id="acn3551-fig-0001" orientation="portrait" position="float" xml:lang="en">
<label>Figure 1</label>
<caption>
<p>Patient flowchart. <styled-content style="fixed-case">CP</styled-content>, cerebral palsy; <styled-content style="fixed-case">CPA</styled-content>, cardiac pulmonary arrest.</p>
</caption>
<graphic id="nlm-graphic-1" xlink:href="ACN3-5-538-g001"></graphic>
</fig>
</sec>
<sec id="acn3551-sec-0008">
<title>Clinical features of case series</title>
<p>For each patient, demographic and clinical data were collected from the patient's chart, which included gender, age, age at diagnosis, details of pregnancy and birth, gestational weeks, birth weight, head circumference, neonatal events, type of CP, comorbidities, brain MRI findings, and functional classification scores for CP, such as the Gross Motor Function Classification Scale,<xref ref-type="ref" rid="acn3551-bib-0010">10</xref> the Manual Ability Classification System,<xref ref-type="ref" rid="acn3551-bib-0011">11</xref> and the Communication Function Classification System.<xref ref-type="ref" rid="acn3551-bib-0012">12</xref> The types of CP (spastic diplegia, ataxic type, diskinetic type, and mixed type) were classified based on previous reports,<xref ref-type="ref" rid="acn3551-bib-0009">9</xref>, <xref ref-type="ref" rid="acn3551-bib-0013">13</xref> and the brain MRI was performed as previously described.<xref ref-type="ref" rid="acn3551-bib-0009">9</xref>
</p>
</sec>
<sec id="acn3551-sec-0009">
<title>aCGH analysis</title>
<p>Microdeletions and microduplications were evaluated using SurePrint G3 CGH+SNP Microarray Kit 4 × 180K (ISCA) (Agilent Technologies, Santa Clara, CA, USA). CNVs were detected using CytoGenomics 2.5 (Agilent Technologies), and their pathogenicity was assessed using the International Standards for Cytogenomic Arrays (ISCA) database, the Database of Genomic Variants,<xref ref-type="ref" rid="acn3551-bib-0014">14</xref> and our in‐house database (<italic>n</italic> = 100).</p>
</sec>
<sec id="acn3551-sec-0010">
<title>WES analysis</title>
<p>We performed trio‐based WES for 17 families. Genomic DNA was captured using SureSelectXT Human All Exon V5 (50 Mb) or V6 (60 Mb) Kits (Agilent Technologies) and sequenced on a HiSeq2500 (Illumina) with 126‐base pair paired‐end reads. The reads were mapped to the hg19 human reference using Burrows‐Wheeler Aligner (BWA) 0.6.2‐r126<xref ref-type="ref" rid="acn3551-bib-0015">15</xref> and single‐nucleotide variants (SNVs), and insertions and/or deletions (indels) were called using the Genome Analysis Toolkit (GATK) v. 1.6–13.<xref ref-type="ref" rid="acn3551-bib-0016">16</xref> After quality filtering steps, variants were annotated using ANNOVAR.<xref ref-type="ref" rid="acn3551-bib-0017">17</xref> We prioritized the variants identified in enrolled CP patients as described below (Fig. <xref ref-type="fig" rid="acn3551-fig-0002">2</xref>). Nonsynonymous SNVs, splice‐site variants and indels were retained. We excluded variants present in the 1000 Genomes database, the National Heart, Lung, and Blood Institute (NHLBI) Exome Sequencing Project (ESP6500), the Exome Aggregation Consortium (ExAC) database version 0.3 (all and East Asian populations), and the Human Genetic Variation Database (HGVD)<xref ref-type="ref" rid="acn3551-bib-0018">18</xref>, <xref ref-type="ref" rid="acn3551-bib-0019">19</xref> to discover rare de novo variants. For the autosomal recessive and X‐linked models, we excluded variants with an allele frequency equal to or greater than 1% in the 1000 Genomes database, the Exome Sequencing Project (ESP) 6500, the ExAC database version 0.3 (all and East Asian populations) and the HGVD. In the autosomal recessive and X‐linked models, autosomal variants with homozygotes found in the databases (or variants on the Chromosome X with hemizygotes in the databases) were filtered. Sorting intolerant from tolerant (SIFT),<xref ref-type="ref" rid="acn3551-bib-0020">20</xref> (polymorphism phenotypinb v2) PolyPhen2 HVAR,<xref ref-type="ref" rid="acn3551-bib-0021">21</xref> the Genomic Evolutionary Rate Profiling (GERP),<xref ref-type="ref" rid="acn3551-bib-0022">22</xref> and combined annotation‐dependent depletion (CADD)<xref ref-type="ref" rid="acn3551-bib-0023">23</xref> scores were used to predict nucleotide‐level conservation and the impact of amino acid substitutions. After extracting rare variants (listed in Table <xref ref-type="supplementary-material" rid="acn3551-sup-0001">S1</xref>), only the rare variants that were present in Online Mendelian Inheritance in Man (OMIM) linked to neurodevelopmental diseases were prioritized as candidate variants. Each candidate variant was interpreted according to the American College of Medical Genetics and Genomics (ACMG) standards and guidelines.<xref ref-type="ref" rid="acn3551-bib-0024">24</xref> All the candidate variants were validated by Sanger sequencing, and the primers used for Sanger sequencing are listed in Table <xref ref-type="supplementary-material" rid="acn3551-sup-0002">S2</xref>.</p>
<fig fig-type="Figure" id="acn3551-fig-0002" orientation="portrait" position="float" xml:lang="en">
<label>Figure 2</label>
<caption>
<p>Schematic map of variants filtering. Rare variants and candidate variants in this figure are shown in Table <xref ref-type="supplementary-material" rid="acn3551-sup-0001">S1</xref> and Table <xref ref-type="table-wrap" rid="acn3551-tbl-0002">2</xref>, respectively. <styled-content style="fixed-case">GQ</styled-content>, genotype quality; <styled-content style="fixed-case">AAR</styled-content>, alternative allele ratio; <styled-content style="fixed-case">AR</styled-content>, autosomal recessive; <styled-content style="fixed-case">XL</styled-content>, X‐linked; <styled-content style="fixed-case">ACMG</styled-content>, the American College of Medical Genetics and Genomics* “Databases” include the 1000 Genomes database (all and East Asian populations), the <styled-content style="fixed-case">ESP</styled-content>6500, the Ex<styled-content style="fixed-case">AC</styled-content> database version 0.3 (all and East Asian populations) and the <styled-content style="fixed-case">HGVD</styled-content>.</p>
</caption>
<graphic id="nlm-graphic-3" xlink:href="ACN3-5-538-g002"></graphic>
</fig>
</sec>
<sec id="acn3551-sec-0011">
<title>Extraction of RNA and reverse transcription‐polymerase chain reaction (RT‐PCR)</title>
<p>To demonstrate aberrant splicing of <italic>CTNNB1</italic> (case 3) and <italic>AMPD2</italic> (case 11) derived from each variant, whole blood was collected using a PAXgene RNA Blood RNA Kit (QIAGEN, Hilden, Germany) from each patient and two healthy controls. The RNA samples were extracted from fresh blood samples using a QIAamp RNA Blood Mini Kit (QIAGEN, Hilden, Germany) according to the manufacturer's instructions. The cDNA was synthesized using a PrimeScript RT (reverse transcription) reagent Kit with gDNA Eraser (TaKaRa, Shiga, Japan) according to the manufacturer's instructions. <italic>CTNNB1</italic> and <italic>AMPD2</italic> cDNA were amplified using TaKaRa ExTaq Hot Start Version (TaKaRa, Shiga, Japan), followed by agarose gel electrophoresis and analyzed by bidirectional Sanger sequencing. The primers are listed in Table <xref ref-type="supplementary-material" rid="acn3551-sup-0002">S2</xref>.</p>
</sec>
<sec id="acn3551-sec-0012">
<title>AMP deaminase assay</title>
<p>White blood cells (WBCs) were extracted from the heparinized whole blood of two patients (case 3 and case 11) and two healthy volunteers to establish lymphoblastoid cell lines (LCLs) infected with Epstein–Barr virus (EBV) as previously described.<xref ref-type="ref" rid="acn3551-bib-0025">25</xref> AMPD2 enzyme activity in the WBCs was analyzed using these EBV‐infected LCLs (EBV‐LCLs). AMP deaminase activity in EBV‐LCL cells was assessed as previously described<xref ref-type="ref" rid="acn3551-bib-0026">26</xref> with minor modifications. Briefly, the cells were lysed in ice‐cold buffer A (250 mmol/L sucrose, 150 mmol/L KCl, 20 mmol/L imidazole HCl), and the protein concentration in the supernatant was measured with a Pierce BCA Protein Assay Kit (Thermo Scientific, Waltham, MA, USA). Extracts containing 2 <italic>μ</italic>g of total protein were mixed with 50 mmol/L sodium citrate (pH 7), 50 mmol/L KCl, and 4 mmol/L AMP. For each protein extract a reaction mixture without AMP was prepared for background quantification. After 1 hour of incubation at 25°C, 50 <italic>μ</italic>L of the previous reaction mixture and 100 <italic>μ</italic>L of reagent A (10 mmol/L phenol, 20 mmol/L sodium nitroprusside) were transferred to the wells of a 96‐well plate containing the previous reaction samples and 100 <italic>μ</italic>L of reagent B (12.5 mmol/L sodium hydroxide, 20 mmol/L dibasic sodium phosphate, 0.01% sodium hypochlorite) was then added. After 3 h of incubation at 25°C, the absorbance of the samples was measured at 625 nm using a SPECTRA Max 190 microplate reader (Molecular Devices, Sunnyvale, CA) against a reagent blank. An ammonia standard was prepared from ammonium sulfate to quantify the amount of ammonia formed by the cell extracts during incubation with AMP. To minimize variability in each experiment, the results were calculated from the ratio of absorbance in each sample to the average concentration in three control samples (case 3 and 2 healthy controls). Statistical analysis was performed using one‐way analysis of variance with a Dunnett's test for unequal variance.</p>
</sec>
</sec>
<sec id="acn3551-sec-0013">
<title>Results</title>
<sec id="acn3551-sec-0014">
<title>Characteristics of the participants</title>
<p>A total of 17 cases and their parents were enrolled and analyzed, as shown in Figure <xref ref-type="fig" rid="acn3551-fig-0001">1</xref>. Overall, 11 participants were male (64.7%) with a median age of 9.5 years (range, 3–30 years) and all participants were Japanese and nonconsanguineous. The median age at diagnosis of CP and follow‐up period was 40 months (range, 16–178 months) and 84 months (range, 26–358 months), respectively. This case series was classified into four CP types: spastic diplegia (11, 64.7%), dyskinetic type (3, 17.6%), ataxic type (2, 11.8%), and mixed type (1, 5.9%). All exhibited sporadic onset under 2 years of age, and their condition was nonprogressive, which is compatible with the definition of CP.<xref ref-type="ref" rid="acn3551-bib-0001">1</xref> None of the family histories of the cases were significant. Only case 2 underwent neonatal resuscitation with mask‐bag ventilation. Ten cases (58.8%) had normal brain MRI findings, and the others had nonspecific findings. The nonspecific brain MRI findings are shown (Fig. <xref ref-type="fig" rid="acn3551-fig-0003">3</xref>). All cases except case 4 (94.1%) exhibited intellectual disability at the last follow‐up. The clinical characteristics of these cases are described in Table <xref ref-type="table-wrap" rid="acn3551-tbl-0001">1</xref> (see also Appendix <xref ref-type="supplementary-material" rid="acn3551-sup-0002">S1</xref>).</p>
<fig fig-type="Figure" id="acn3551-fig-0003" orientation="portrait" position="float" xml:lang="en">
<label>Figure 3</label>
<caption>
<p>Nonspecific brain findings on T2‐weighted <styled-content style="fixed-case">MRI</styled-content>. (A) Case 5; mild hyperintensity of the deep white matter around the body of the left lateral ventricle. (B) Case 7; slight hyperintensity of the left pars triangularis. (C) Case 11; hyperintensity in the striatum and a thin corpus callosum. (D) Case 13; a thin corpus callosum and mildly enlarged lateral ventricle. (E) Case 14; a thin corpus callosum and cerebral white matter atrophy. (F) Case 16; slight bilateral hyperintensities in the pallidum.</p>
</caption>
<graphic id="nlm-graphic-5" xlink:href="ACN3-5-538-g003"></graphic>
</fig>
<table-wrap id="acn3551-tbl-0001" orientation="portrait" position="float" xml:lang="en">
<label>Table 1</label>
<caption>
<p>Clinical features of case series</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Case</th>
<th align="center" colspan="1" rowspan="1" valign="top">Gender</th>
<th align="center" colspan="1" rowspan="1" valign="top">Age, y</th>
<th align="center" colspan="1" rowspan="1" valign="top">Age at CP diagnosis, m</th>
<th align="center" colspan="1" rowspan="1" valign="top">Follow ‐up period, m</th>
<th align="center" colspan="1" rowspan="1" valign="top">CP type</th>
<th align="center" colspan="1" rowspan="1" valign="top">GW</th>
<th align="center" colspan="1" rowspan="1" valign="top">BW at birth (SD), g</th>
<th align="center" colspan="1" rowspan="1" valign="top">HC at birth (SD), cm</th>
<th align="center" colspan="1" rowspan="1" valign="top">Perinatal complications</th>
<th align="center" colspan="1" rowspan="1" valign="top">Brain MRI findings</th>
<th align="center" colspan="1" rowspan="1" valign="top">Intellectual disability</th>
<th align="center" colspan="1" rowspan="1" valign="top">Epilepsy</th>
<th align="center" colspan="1" rowspan="1" valign="top">Autistic features</th>
<th align="center" colspan="1" rowspan="1" valign="top">Other comorbidities</th>
<th align="center" colspan="1" rowspan="1" valign="top">GMFCS</th>
<th align="center" colspan="1" rowspan="1" valign="top">MACS</th>
<th align="center" colspan="1" rowspan="1" valign="top">CFCS</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">1</td>
<td align="char" char="." colspan="1" rowspan="1">M</td>
<td align="char" char="." colspan="1" rowspan="1">8</td>
<td align="char" char="." colspan="1" rowspan="1">23</td>
<td align="char" char="." colspan="1" rowspan="1">91</td>
<td align="char" char="." colspan="1" rowspan="1">D</td>
<td align="char" char="." colspan="1" rowspan="1">40</td>
<td align="char" char=" " colspan="1" rowspan="1">3066 (−0.5)</td>
<td align="char" char="." colspan="1" rowspan="1">34.0 (+0.5)</td>
<td align="char" char="." colspan="1" rowspan="1">–</td>
<td align="char" char="." colspan="1" rowspan="1">Normal</td>
<td align="char" char="." colspan="1" rowspan="1">Yes</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">Optic nerve atrophy</td>
<td align="char" char="." colspan="1" rowspan="1">5</td>
<td align="char" char="." colspan="1" rowspan="1">5</td>
<td align="char" char="." colspan="1" rowspan="1">3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">2</td>
<td align="char" char="." colspan="1" rowspan="1">M</td>
<td align="char" char="." colspan="1" rowspan="1">30</td>
<td align="char" char="." colspan="1" rowspan="1">74</td>
<td align="char" char="." colspan="1" rowspan="1">358</td>
<td align="char" char="." colspan="1" rowspan="1">S</td>
<td align="char" char="." colspan="1" rowspan="1">41</td>
<td align="char" char=" " colspan="1" rowspan="1">3310 (−0.3)</td>
<td align="char" char="." colspan="1" rowspan="1">N/D</td>
<td align="char" char="." colspan="1" rowspan="1">
Neonatal Resuscitation<break></break>
MAS/PDA
</td>
<td align="char" colspan="1" rowspan="1">Normal</td>
<td align="char" char="." colspan="1" rowspan="1">Yes</td>
<td align="char" char="." colspan="1" rowspan="1">Yes</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">Microcephaly</td>
<td align="char" char="." colspan="1" rowspan="1">2</td>
<td align="char" char="." colspan="1" rowspan="1">4</td>
<td align="char" char="." colspan="1" rowspan="1">4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">3</td>
<td align="char" char="." colspan="1" rowspan="1">M</td>
<td align="char" char="." colspan="1" rowspan="1">7</td>
<td align="char" char="." colspan="1" rowspan="1">58</td>
<td align="char" char="." colspan="1" rowspan="1">87</td>
<td align="char" char="." colspan="1" rowspan="1">S</td>
<td align="char" char="." colspan="1" rowspan="1">40</td>
<td align="char" char="." colspan="1" rowspan="1">3428 (+0.7)</td>
<td align="char" char="." colspan="1" rowspan="1">35.0 (+1.1)</td>
<td align="char" char="." colspan="1" rowspan="1">–</td>
<td align="char" char="." colspan="1" rowspan="1">Normal</td>
<td align="char" char="." colspan="1" rowspan="1">Yes</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">Hyperekplexia</td>
<td align="char" char="." colspan="1" rowspan="1">4</td>
<td align="char" char="." colspan="1" rowspan="1">3</td>
<td align="char" char="." colspan="1" rowspan="1">3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">4</td>
<td align="char" char="." colspan="1" rowspan="1">M</td>
<td align="char" char="." colspan="1" rowspan="1">9</td>
<td align="char" char="." colspan="1" rowspan="1">51</td>
<td align="char" char="." colspan="1" rowspan="1">63</td>
<td align="char" char="." colspan="1" rowspan="1">S</td>
<td align="char" char="." colspan="1" rowspan="1">38</td>
<td align="char" char=" " colspan="1" rowspan="1">3208 (−0.4)</td>
<td align="char" char=" " colspan="1" rowspan="1">33.5 (−0.5)</td>
<td align="char" char="." colspan="1" rowspan="1">–</td>
<td align="char" char="." colspan="1" rowspan="1">Normal</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">–</td>
<td align="char" char="." colspan="1" rowspan="1">3</td>
<td align="char" char="." colspan="1" rowspan="1">1</td>
<td align="char" char="." colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">5</td>
<td align="char" char="." colspan="1" rowspan="1">M</td>
<td align="char" char="." colspan="1" rowspan="1">22</td>
<td align="char" char="." colspan="1" rowspan="1">38</td>
<td align="char" char="." colspan="1" rowspan="1">260</td>
<td align="char" char="." colspan="1" rowspan="1">S</td>
<td align="char" char="." colspan="1" rowspan="1">37</td>
<td align="char" char=" " colspan="1" rowspan="1">2890 (−0.4)</td>
<td align="char" char=" " colspan="1" rowspan="1">32.5 (−0.5)</td>
<td align="char" char="." colspan="1" rowspan="1">–</td>
<td align="char" char="." colspan="1" rowspan="1">DWMH</td>
<td align="char" char="." colspan="1" rowspan="1">Yes</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">–</td>
<td align="char" char="." colspan="1" rowspan="1">4</td>
<td align="char" char="." colspan="1" rowspan="1">5</td>
<td align="char" char="." colspan="1" rowspan="1">2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">6</td>
<td align="char" char="." colspan="1" rowspan="1">M</td>
<td align="char" char="." colspan="1" rowspan="1">7</td>
<td align="char" char="." colspan="1" rowspan="1">30</td>
<td align="char" char="." colspan="1" rowspan="1">64</td>
<td align="left" colspan="1" rowspan="1">S</td>
<td align="left" colspan="1" rowspan="1">37</td>
<td align="left" colspan="1" rowspan="1">3182 (+1.0)</td>
<td align="left" colspan="1" rowspan="1">N/D</td>
<td align="char" char="." colspan="1" rowspan="1">–</td>
<td align="char" colspan="1" rowspan="1">Normal</td>
<td align="char" char="." colspan="1" rowspan="1">Yes</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">–</td>
<td align="char" char="." colspan="1" rowspan="1">2</td>
<td align="char" char="." colspan="1" rowspan="1">1</td>
<td align="char" char="." colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">7</td>
<td align="char" char="." colspan="1" rowspan="1">F</td>
<td align="char" char="." colspan="1" rowspan="1">7</td>
<td align="char" char="." colspan="1" rowspan="1">16</td>
<td align="char" char="." colspan="1" rowspan="1">81</td>
<td align="left" colspan="1" rowspan="1">D</td>
<td align="left" colspan="1" rowspan="1">38</td>
<td align="char" char=" " colspan="1" rowspan="1">2780 (−0.6)</td>
<td align="char" char=" " colspan="1" rowspan="1">32.5 (−0.5)</td>
<td align="char" char="." colspan="1" rowspan="1">–</td>
<td align="char" colspan="1" rowspan="1">DWMH</td>
<td align="char" char="." colspan="1" rowspan="1">Yes</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">–</td>
<td align="char" char="." colspan="1" rowspan="1">5</td>
<td align="char" char="." colspan="1" rowspan="1">5</td>
<td align="char" char="." colspan="1" rowspan="1">4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">8</td>
<td align="char" char="." colspan="1" rowspan="1">M</td>
<td align="char" char="." colspan="1" rowspan="1">15</td>
<td align="char" char="." colspan="1" rowspan="1">164</td>
<td align="char" char="." colspan="1" rowspan="1">26</td>
<td align="left" colspan="1" rowspan="1">S</td>
<td align="left" colspan="1" rowspan="1">40</td>
<td align="char" char=" " colspan="1" rowspan="1">3120 (−0.5)</td>
<td align="char" char=" " colspan="1" rowspan="1">34.0 (−0.5)</td>
<td align="char" char="." colspan="1" rowspan="1">–</td>
<td align="char" colspan="1" rowspan="1">Normal</td>
<td align="char" char="." colspan="1" rowspan="1">Yes</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">Yes</td>
<td align="char" char="." colspan="1" rowspan="1">Irritability</td>
<td align="char" char="." colspan="1" rowspan="1">1</td>
<td align="char" char="." colspan="1" rowspan="1">2</td>
<td align="char" char="." colspan="1" rowspan="1">2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">9</td>
<td align="char" char="." colspan="1" rowspan="1">F</td>
<td align="char" char="." colspan="1" rowspan="1">13</td>
<td align="char" char="." colspan="1" rowspan="1">116</td>
<td align="char" char="." colspan="1" rowspan="1">46</td>
<td align="left" colspan="1" rowspan="1">AT</td>
<td align="left" colspan="1" rowspan="1">41</td>
<td align="left" colspan="1" rowspan="1">3548 (+1.3)</td>
<td align="char" char=" " colspan="1" rowspan="1">32.5 (−0.5)</td>
<td align="char" char="." colspan="1" rowspan="1">–</td>
<td align="char" colspan="1" rowspan="1">Normal</td>
<td align="char" char="." colspan="1" rowspan="1">Yes</td>
<td align="char" char="." colspan="1" rowspan="1">Yes</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1">4</td>
<td align="char" char="." colspan="1" rowspan="1">4</td>
<td align="char" char="." colspan="1" rowspan="1">4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">10</td>
<td align="char" char="." colspan="1" rowspan="1">M</td>
<td align="char" char="." colspan="1" rowspan="1">8</td>
<td align="char" char="." colspan="1" rowspan="1">26</td>
<td align="char" char="." colspan="1" rowspan="1">87</td>
<td align="left" colspan="1" rowspan="1">S</td>
<td align="left" colspan="1" rowspan="1">40</td>
<td align="left" colspan="1" rowspan="1">3086 (+0.0)</td>
<td align="char" char=" " colspan="1" rowspan="1">33.0 (−0.3)</td>
<td align="char" char="." colspan="1" rowspan="1">–</td>
<td align="char" colspan="1" rowspan="1">Normal</td>
<td align="char" char="." colspan="1" rowspan="1">Yes</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">–</td>
<td align="char" char="." colspan="1" rowspan="1">4</td>
<td align="char" char="." colspan="1" rowspan="1">3</td>
<td align="char" char="." colspan="1" rowspan="1">2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">11</td>
<td align="char" char="." colspan="1" rowspan="1">F</td>
<td align="char" char="." colspan="1" rowspan="1">5</td>
<td align="char" char="." colspan="1" rowspan="1">22</td>
<td align="char" char="." colspan="1" rowspan="1">51</td>
<td align="left" colspan="1" rowspan="1">S</td>
<td align="left" colspan="1" rowspan="1">38</td>
<td align="char" char=" " colspan="1" rowspan="1">2554 (−0.6)</td>
<td align="char" char=" " colspan="1" rowspan="1">30.0 (−2.2)</td>
<td align="char" char="." colspan="1" rowspan="1">–</td>
<td align="char" colspan="1" rowspan="1">BG hyperintensityWM atrophy</td>
<td align="char" char="." colspan="1" rowspan="1">Yes</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">Yes</td>
<td align="char" char="." colspan="1" rowspan="1">Irritability</td>
<td align="char" char="." colspan="1" rowspan="1">4</td>
<td align="char" char="." colspan="1" rowspan="1">4</td>
<td align="char" char="." colspan="1" rowspan="1">5</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">12</td>
<td align="char" char="." colspan="1" rowspan="1">F</td>
<td align="char" char="." colspan="1" rowspan="1">3</td>
<td align="char" char="." colspan="1" rowspan="1">31</td>
<td align="char" char="." colspan="1" rowspan="1">32</td>
<td align="left" colspan="1" rowspan="1">AT</td>
<td align="left" colspan="1" rowspan="1">39</td>
<td align="left" colspan="1" rowspan="1">3134 (+0.4)</td>
<td align="char" char=" " colspan="1" rowspan="1">33.0 (−1.1)</td>
<td align="char" char=" " colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">Normal</td>
<td align="char" char="." colspan="1" rowspan="1">Yes</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">Intention tremor</td>
<td align="char" char="." colspan="1" rowspan="1">2</td>
<td align="char" char="." colspan="1" rowspan="1">4</td>
<td align="char" char="." colspan="1" rowspan="1">4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">13</td>
<td align="char" char="." colspan="1" rowspan="1">M</td>
<td align="char" char="." colspan="1" rowspan="1">10</td>
<td align="char" char="." colspan="1" rowspan="1">40</td>
<td align="char" char="." colspan="1" rowspan="1">84</td>
<td align="left" colspan="1" rowspan="1">S</td>
<td align="left" colspan="1" rowspan="1">40</td>
<td align="left" colspan="1" rowspan="1">3304 (+0.6)</td>
<td align="char" char=" " colspan="1" rowspan="1">31.8 (−1.2)</td>
<td align="char" char=" " colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">WM atrophy</td>
<td align="char" char="." colspan="1" rowspan="1">Yes</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">Yes</td>
<td align="char" char=" " colspan="1" rowspan="1">−</td>
<td align="char" char="." colspan="1" rowspan="1">1</td>
<td align="char" char="." colspan="1" rowspan="1">2</td>
<td align="char" char="." colspan="1" rowspan="1">2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">14</td>
<td align="char" char="." colspan="1" rowspan="1">F</td>
<td align="char" char="." colspan="1" rowspan="1">22</td>
<td align="char" char="." colspan="1" rowspan="1">27</td>
<td align="char" char="." colspan="1" rowspan="1">263</td>
<td align="left" colspan="1" rowspan="1">S</td>
<td align="left" colspan="1" rowspan="1">40</td>
<td align="char" char=" " colspan="1" rowspan="1">2930 (−0.2)</td>
<td align="char" char=" " colspan="1" rowspan="1">31.5 (−1.4)</td>
<td align="char" char=" " colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">Cortical atrophy</td>
<td align="char" char="." colspan="1" rowspan="1">Yes</td>
<td align="char" char="." colspan="1" rowspan="1">Yes</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char=" " colspan="1" rowspan="1">−</td>
<td align="char" char="." colspan="1" rowspan="1">4</td>
<td align="char" char="." colspan="1" rowspan="1">4</td>
<td align="char" char="." colspan="1" rowspan="1">5</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">15</td>
<td align="char" char="." colspan="1" rowspan="1">F</td>
<td align="char" char="." colspan="1" rowspan="1">6</td>
<td align="char" char="." colspan="1" rowspan="1">56</td>
<td align="char" char="." colspan="1" rowspan="1">82</td>
<td align="left" colspan="1" rowspan="1">Mix (S, AT)</td>
<td align="left" colspan="1" rowspan="1">37</td>
<td align="char" char=" " colspan="1" rowspan="1">1736 (−2.6)</td>
<td align="char" char=" " colspan="1" rowspan="1">31.0 (−1.2)</td>
<td align="char" char="." colspan="1" rowspan="1">SGA</td>
<td align="char" colspan="1" rowspan="1">Normal</td>
<td align="char" char="." colspan="1" rowspan="1">Yes</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">VATER association</td>
<td align="char" char="." colspan="1" rowspan="1">2</td>
<td align="char" char="." colspan="1" rowspan="1">3</td>
<td align="char" char="." colspan="1" rowspan="1">3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">16</td>
<td align="char" char="." colspan="1" rowspan="1">M</td>
<td align="char" char="." colspan="1" rowspan="1">11</td>
<td align="char" char="." colspan="1" rowspan="1">25</td>
<td align="char" char="." colspan="1" rowspan="1">130</td>
<td align="left" colspan="1" rowspan="1">D</td>
<td align="left" colspan="1" rowspan="1">37</td>
<td align="left" colspan="1" rowspan="1">3298 (+1.7)</td>
<td align="left" colspan="1" rowspan="1">35.5 (+2.1)</td>
<td align="char" char="." colspan="1" rowspan="1">–</td>
<td align="char" colspan="1" rowspan="1">BG hyperintensity</td>
<td align="char" char="." colspan="1" rowspan="1">Yes</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">–</td>
<td align="char" char="." colspan="1" rowspan="1">4</td>
<td align="char" char="." colspan="1" rowspan="1">3</td>
<td align="char" char="." colspan="1" rowspan="1">3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">17</td>
<td align="char" char="." colspan="1" rowspan="1">M</td>
<td align="char" char="." colspan="1" rowspan="1">19</td>
<td align="char" char="." colspan="1" rowspan="1">178</td>
<td align="char" char="." colspan="1" rowspan="1">76</td>
<td align="left" colspan="1" rowspan="1">S</td>
<td align="left" colspan="1" rowspan="1">37</td>
<td align="left" colspan="1" rowspan="1">3094 (+1.1)</td>
<td align="left" colspan="1" rowspan="1">36.0 (+2.5)</td>
<td align="char" char="." colspan="1" rowspan="1">–</td>
<td align="char" colspan="1" rowspan="1">Normal</td>
<td align="char" char="." colspan="1" rowspan="1">Yes</td>
<td align="char" char="." colspan="1" rowspan="1">Yes</td>
<td align="char" char="." colspan="1" rowspan="1">Yes</td>
<td align="char" char="." colspan="1" rowspan="1">Hemolysis</td>
<td align="char" char="." colspan="1" rowspan="1">2</td>
<td align="char" char="." colspan="1" rowspan="1">4</td>
<td align="char" char="." colspan="1" rowspan="1">5</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="acn3551-note-0002">
<p>CP, cerebral palsy; GW, gestational weeks; BW, birth weight; SD, standard deviation; HC, head circumference; MRI, magnetic resonance imaging; GMFCS, gross motor function classification; MACS, manual ability classification system; CFCS, communication function classification system; S, spastic diplegia; D, dyskinetic; AT, ataxic; N/D, no data; MAS, meconium aspiration syndrome; PDA, patent ductus arteriosus; SGA, small for gestational age; DWMH, Deep White matter hyperintensity; BG, basal ganglia; WM, white matter; ASD, autism spectrum disorder.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
</sec>
<sec id="acn3551-sec-0015">
<title>aCGH analysis</title>
<p>No CNVs were suspected to be pathogenically related to the phenotype of CP with aCGH. Only case 2 was identified as having X chromosome duplication and was confirmed to have XXY karyotypes in G‐banding, which is not closely related to CP.</p>
</sec>
<sec id="acn3551-sec-0016">
<title>WES analysis</title>
<p>The average mean depth was ×114. We obtained 17 clinically relevant candidate variants in 64.7% of the cases (11 of 17 cases) (Table <xref ref-type="table-wrap" rid="acn3551-tbl-0002">2</xref>). Of these cases, eight variants in seven cases within six genes: <italic>CTNNB1</italic>,<italic> CYP2U1</italic>,<italic> SPAST</italic>,<italic> GNAO1</italic>,<italic> CACNA1A</italic>, and <italic>AMPD2</italic>, were classified as pathogenic (41.2%) and the other two variants in two cases within two genes: <italic>STXBP1</italic> and <italic>SCN2A</italic> were likely pathogenic (11.8%) according to the ACMG standards and guidelines (Table <xref ref-type="table-wrap" rid="acn3551-tbl-0002">2</xref>). Most of the pathogenic/likely pathogenic variants identified in the nine cases were de novo (77.8%, 7 of 9). Two of the cases had autosomal recessive inheritance including one case of compound heterozygosity. One identified gene, <italic>SPAST</italic>, was found in two cases (case 6 and 10). Among the causative variants identified in the nine patients, the variants in <italic>SPAST</italic>,<italic> GNAO1</italic>,<italic> CACNA1A,</italic> and <italic>STXBP1</italic> have been previously reported,<xref ref-type="ref" rid="acn3551-bib-0027">27</xref>, <xref ref-type="ref" rid="acn3551-bib-0028">28</xref>, <xref ref-type="ref" rid="acn3551-bib-0029">29</xref>, <xref ref-type="ref" rid="acn3551-bib-0030">30</xref>, <xref ref-type="ref" rid="acn3551-bib-0031">31</xref>, <xref ref-type="ref" rid="acn3551-bib-0032">32</xref> whereas the variants in the other genes (<italic>CTNNB1</italic>,<italic> CYP2U1</italic>,<italic> AMPD2</italic>, and <italic>SCN2A</italic>) were novel. Of all the identified candidate genes, only <italic>SPAST</italic>,<italic> STXBP1</italic>, and <italic>SPTBN2</italic> have been previously reported in CP patients.<xref ref-type="ref" rid="acn3551-bib-0033">33</xref>, <xref ref-type="ref" rid="acn3551-bib-0034">34</xref>, <xref ref-type="ref" rid="acn3551-bib-0035">35</xref> In five cases, we identified eight unknown significant candidate variants of five genes (<italic>UBA1</italic>,<italic> AMER1</italic>,<italic> FAT4</italic>,<italic> GPR98</italic>, and <italic>SPTBN2</italic>). None of the variants except p.(Arg524Trp) in <italic>SPTBN2</italic> were associated with any evidence, such as functional analysis, previous reports, evolutionary conservation, or computational predictive programs, suggesting that they were a cause of disease. Thus, we did not pursue those candidate variants in this study.</p>
<table-wrap id="acn3551-tbl-0002" orientation="portrait" position="float" xml:lang="en">
<label>Table 2</label>
<caption>
<p>Cases with pathogenic or potentially pathogenic variants identified by trio WES analysis and the result of aCGH analysis</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Case</th>
<th align="center" colspan="1" rowspan="1" valign="top">CNVs</th>
<th align="center" colspan="1" rowspan="1" valign="top">Gene</th>
<th align="center" colspan="1" rowspan="1" valign="top">OMIM</th>
<th align="center" colspan="1" rowspan="1" valign="top">OMIM disease</th>
<th align="center" colspan="1" rowspan="1" valign="top">Previous report of CP</th>
<th align="center" colspan="1" rowspan="1" valign="top">Inheritance</th>
<th align="center" colspan="1" rowspan="1" valign="top">Position (hg19)</th>
<th align="center" colspan="1" rowspan="1" valign="top">Effect on Protein</th>
<th align="center" colspan="1" rowspan="1" valign="top">Protein change</th>
<th align="center" colspan="1" rowspan="1" valign="top">Previously reported vaiant</th>
<th align="center" colspan="1" rowspan="1" valign="top">SIFT score</th>
<th align="center" colspan="1" rowspan="1" valign="top">Polyphen2 HVAR</th>
<th align="center" colspan="1" rowspan="1" valign="top">CADD phred</th>
<th align="center" colspan="1" rowspan="1" valign="top">GERP‐RS</th>
<th align="center" colspan="1" rowspan="1" valign="top">ExAC</th>
<th align="center" colspan="1" rowspan="1" valign="top">Pathogenicity</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="16" rowspan="1">Pathogenic/likely pathogenic candidate variants</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">3</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">
<italic>CTNNB1</italic>
</td>
<td align="left" colspan="1" rowspan="1">114550</td>
<td align="left" colspan="1" rowspan="1">Intellectual disability</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">De novo</td>
<td align="left" colspan="1" rowspan="1">Chr3:41275790 T &gt; C</td>
<td align="left" colspan="1" rowspan="1">Splice site change</td>
<td align="left" colspan="1" rowspan="1">p.Glu562AlafsTer11</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">NA</td>
<td align="char" char="." colspan="1" rowspan="1">NA</td>
<td align="char" char="." colspan="1" rowspan="1">22.9</td>
<td align="char" char="." colspan="1" rowspan="1">5.66</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">Pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">5</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">
<italic>CYP2U1</italic>
</td>
<td align="left" colspan="1" rowspan="1">610670</td>
<td align="left" colspan="1" rowspan="1">Spastic paraplegia</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">AR‐homozygous</td>
<td align="left" colspan="1" rowspan="1">Chr4:108866283 del C</td>
<td align="left" colspan="1" rowspan="1">Frame shift</td>
<td align="left" colspan="1" rowspan="1">p.(Phe218fsTer42)</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">NA</td>
<td align="char" char="." colspan="1" rowspan="1">NA</td>
<td align="char" char="." colspan="1" rowspan="1">NA</td>
<td align="char" char="." colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">Pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">6</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">
<italic>SPAST</italic>
</td>
<td align="left" colspan="1" rowspan="1">604277</td>
<td align="left" colspan="1" rowspan="1">Spastic paraplegia</td>
<td align="char" char="." colspan="1" rowspan="1">Yes</td>
<td align="left" colspan="1" rowspan="1">De novo</td>
<td align="left" colspan="1" rowspan="1">Chr2:32361662 C &gt; T</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="left" colspan="1" rowspan="1">p.(Leu426Phe)</td>
<td align="char" char="." colspan="1" rowspan="1">Yes</td>
<td align="char" char="." colspan="1" rowspan="1">0.002</td>
<td align="char" char="." colspan="1" rowspan="1">0.999</td>
<td align="char" char="." colspan="1" rowspan="1">32</td>
<td align="char" char="." colspan="1" rowspan="1">5.62</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">Pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">7</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">
<italic>GNAO1</italic>
</td>
<td align="left" colspan="1" rowspan="1">139311</td>
<td align="left" colspan="1" rowspan="1">EIEE</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">De novo</td>
<td align="left" colspan="1" rowspan="1">Chr16:56385308 G &gt; A</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="left" colspan="1" rowspan="1">p.(Glu246Lys)</td>
<td align="char" char="." colspan="1" rowspan="1">Yes</td>
<td align="char" char="." colspan="1" rowspan="1">0</td>
<td align="char" char="." colspan="1" rowspan="1">1</td>
<td align="char" char="." colspan="1" rowspan="1">22.7</td>
<td align="char" char="." colspan="1" rowspan="1">5.91</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">Pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">9</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">
<italic>CACNA1A</italic>
</td>
<td align="left" colspan="1" rowspan="1">601011</td>
<td align="left" colspan="1" rowspan="1">Spinocerebellar ataxia EIEE</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">De novo</td>
<td align="left" colspan="1" rowspan="1">Chr19:13476262 G &gt; A</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="left" colspan="1" rowspan="1">p.(Ser218Leu)</td>
<td align="char" char="." colspan="1" rowspan="1">Yes</td>
<td align="char" char="." colspan="1" rowspan="1">0.002</td>
<td align="char" char="." colspan="1" rowspan="1">0.998</td>
<td align="char" char="." colspan="1" rowspan="1">33</td>
<td align="char" char="." colspan="1" rowspan="1">5.55</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">Pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">10</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">
<italic>SPAST</italic>
</td>
<td align="left" colspan="1" rowspan="1">604277</td>
<td align="left" colspan="1" rowspan="1">Spastic paraplegia</td>
<td align="char" char="." colspan="1" rowspan="1">Yes</td>
<td align="left" colspan="1" rowspan="1">De novo</td>
<td align="left" colspan="1" rowspan="1">Chr2:32366975 G &gt; A</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="left" colspan="1" rowspan="1">p.(Arg499His)</td>
<td align="char" char="." colspan="1" rowspan="1">Yes</td>
<td align="char" char="." colspan="1" rowspan="1">0</td>
<td align="char" char="." colspan="1" rowspan="1">1</td>
<td align="char" char="." colspan="1" rowspan="1">34</td>
<td align="char" char="." colspan="1" rowspan="1">4.98</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">Pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" style="padding-left:10%">11</td>
<td align="char" char="." colspan="1" rowspan="2">No</td>
<td align="char" char="." colspan="1" rowspan="2">
<italic>AMPD2</italic>
</td>
<td align="left" colspan="1" rowspan="2">102771</td>
<td align="left" colspan="1" rowspan="2">
Spastic paraplegia<break></break>
Pontocerebellar hypoplasia
</td>
<td align="char" char="." colspan="1" rowspan="2">No</td>
<td align="left" colspan="1" rowspan="2">AR‐Compound heterozygous</td>
<td align="left" colspan="1" rowspan="1">Chr1:110168415 G &gt; A</td>
<td align="left" colspan="1" rowspan="1">Splice site change</td>
<td align="left" colspan="1" rowspan="1">p.Leu173Ter</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">NA</td>
<td align="char" char="." colspan="1" rowspan="1">NA</td>
<td align="char" char="." colspan="1" rowspan="1">25.9</td>
<td align="char" char="." colspan="1" rowspan="1">4.59</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">Pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Chr1:110171419 C &gt; T</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="left" colspan="1" rowspan="1">p.(Pro456Leu)</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">0</td>
<td align="char" char="." colspan="1" rowspan="1">1</td>
<td align="char" char="." colspan="1" rowspan="1">34</td>
<td align="char" char="." colspan="1" rowspan="1">5.08</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">Pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">12</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">
<italic>STXBP1</italic>
</td>
<td align="left" colspan="1" rowspan="1">612164</td>
<td align="left" colspan="1" rowspan="1">EIEE</td>
<td align="char" char="." colspan="1" rowspan="1">Yes</td>
<td align="left" colspan="1" rowspan="1">De novo</td>
<td align="left" colspan="1" rowspan="1">Chr9:130428484 C &gt; G</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="left" colspan="1" rowspan="1">p.(Arg235Gly)</td>
<td align="char" char="." colspan="1" rowspan="1">Yes</td>
<td align="char" char="." colspan="1" rowspan="1">0</td>
<td align="char" char="." colspan="1" rowspan="1">1</td>
<td align="char" char="." colspan="1" rowspan="1">34</td>
<td align="char" char="." colspan="1" rowspan="1">5.72</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">Likely Pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">17</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">
<italic>SCN2A</italic>
</td>
<td align="left" colspan="1" rowspan="1">607745</td>
<td align="left" colspan="1" rowspan="1">EIEE</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">De novo</td>
<td align="left" colspan="1" rowspan="1">Chr2:166245610 T &gt; C</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="left" colspan="1" rowspan="1">p.(Leu1765Pro)</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">0</td>
<td align="char" char="." colspan="1" rowspan="1">1</td>
<td align="char" char="." colspan="1" rowspan="1">25.6</td>
<td align="char" char="." colspan="1" rowspan="1">5.72</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">Likely Pathogenic</td>
</tr>
<tr>
<td align="left" colspan="16" rowspan="1">Unknown significance candidate variants</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">2</td>
<td align="char" char="." colspan="1" rowspan="1">dupX</td>
<td align="char" char="." colspan="1" rowspan="1">
<italic>UBA1</italic>
</td>
<td align="left" colspan="1" rowspan="1">301830</td>
<td align="left" colspan="1" rowspan="1">Spinal muscular atrophy</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">X‐linked</td>
<td align="left" colspan="1" rowspan="1">ChrX:47069086 C &gt; T</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="left" colspan="1" rowspan="1">p.(Thr668Ile)</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">0.05</td>
<td align="char" char="." colspan="1" rowspan="1">0.003</td>
<td align="char" char="." colspan="1" rowspan="1">16.1</td>
<td align="char" char="." colspan="1" rowspan="1">5.22</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">
Unknown<break></break>
Significance
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">6</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">
<italic>AMER1</italic>
</td>
<td align="left" colspan="1" rowspan="1">3006471</td>
<td align="left" colspan="1" rowspan="1">Osteopathia striata with cranial sclerosis</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">X‐linked</td>
<td align="left" colspan="1" rowspan="1">ChrX:63412347 G &gt; A</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="left" colspan="1" rowspan="1">p.(Pro274Ser)</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">0.07</td>
<td align="char" char="." colspan="1" rowspan="1">0.001</td>
<td align="char" char="." colspan="1" rowspan="1">0.61</td>
<td align="char" char="." colspan="1" rowspan="1">0.174</td>
<td align="left" colspan="1" rowspan="1">0.00001</td>
<td align="left" colspan="1" rowspan="1">UnknownSignificance</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" style="padding-left:10%">7</td>
<td align="char" char="." colspan="1" rowspan="2">No</td>
<td align="char" char="." colspan="1" rowspan="2">
<italic>FAT4</italic>
</td>
<td align="left" colspan="1" rowspan="2">615546</td>
<td align="left" colspan="1" rowspan="2">Van Maldergem syndrome</td>
<td align="char" char="." colspan="1" rowspan="2">No</td>
<td align="left" colspan="1" rowspan="2">Compound heterozygous</td>
<td align="left" colspan="1" rowspan="1">Chr4:126238810 C &gt; G</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="left" colspan="1" rowspan="1">p.(Pro415Arg)</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">0.18</td>
<td align="char" char="." colspan="1" rowspan="1">1</td>
<td align="char" char="." colspan="1" rowspan="1">18.22</td>
<td align="char" char="." colspan="1" rowspan="1">4.55</td>
<td align="left" colspan="1" rowspan="1">0.0002</td>
<td align="left" colspan="1" rowspan="1">
Unknown<break></break>
Significance
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Chr4:126411082 A &gt; G</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="left" colspan="1" rowspan="1">p.(Met4370Val)</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">1</td>
<td align="char" char="." colspan="1" rowspan="1">0</td>
<td align="char" char="." colspan="1" rowspan="1">0.027</td>
<td align="char" char="." colspan="1" rowspan="1">0.09</td>
<td align="left" colspan="1" rowspan="1">0.0012</td>
<td align="left" colspan="1" rowspan="1">
Unknown<break></break>
Significance
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" style="padding-left:10%">15</td>
<td align="char" char="." colspan="1" rowspan="2">No</td>
<td align="char" char="." colspan="1" rowspan="2">
<italic>GPR98</italic>
</td>
<td align="left" colspan="1" rowspan="2">602851</td>
<td align="left" colspan="1" rowspan="2">Usher syndrome type2C</td>
<td align="char" char="." colspan="1" rowspan="2">No</td>
<td align="left" colspan="1" rowspan="2">Compound heterozygous</td>
<td align="left" colspan="1" rowspan="1">Chr5:89979443 A &gt; G</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="left" colspan="1" rowspan="1">p.(His1902Arg)</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">0.32</td>
<td align="char" char="." colspan="1" rowspan="1">0</td>
<td align="char" char="." colspan="1" rowspan="1">9.526</td>
<td align="char" char="." colspan="1" rowspan="1">−0.074</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">
Unknown<break></break>
Significance
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Chr5:90086965 A &gt; G</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="left" colspan="1" rowspan="1">p.(Ile4773Met)</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">0.095</td>
<td align="char" char="." colspan="1" rowspan="1">0.859</td>
<td align="char" char="." colspan="1" rowspan="1">21.5</td>
<td align="char" char="." colspan="1" rowspan="1">−10.8</td>
<td align="left" colspan="1" rowspan="1">0.0001</td>
<td align="left" colspan="1" rowspan="1">UnknownSignificance</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" style="padding-left:10%">17</td>
<td align="char" char="." colspan="1" rowspan="2">No</td>
<td align="char" char="." colspan="1" rowspan="2">
<italic>SPTBN2</italic>
</td>
<td align="left" colspan="1" rowspan="2">604985</td>
<td align="left" colspan="1" rowspan="2">Spinocerebellar ataxia</td>
<td align="char" char="." colspan="1" rowspan="2">Yes</td>
<td align="left" colspan="1" rowspan="2">Compound heterozygous</td>
<td align="left" colspan="1" rowspan="1">Chr11:66455748 C &gt; T</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="left" colspan="1" rowspan="1">p.(Arg2089Lys)</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">0.443</td>
<td align="char" char="." colspan="1" rowspan="1">0.009</td>
<td align="char" char="." colspan="1" rowspan="1">0.037</td>
<td align="char" char="." colspan="1" rowspan="1">−6.45</td>
<td align="left" colspan="1" rowspan="1">0.0002</td>
<td align="left" colspan="1" rowspan="1">
Unknown<break></break>
Significance
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Chr11:66475070 G &gt; A</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="left" colspan="1" rowspan="1">p.(Arg524Trp)</td>
<td align="char" char="." colspan="1" rowspan="1">No</td>
<td align="char" char="." colspan="1" rowspan="1">0</td>
<td align="char" char="." colspan="1" rowspan="1">1</td>
<td align="char" char="." colspan="1" rowspan="1">34</td>
<td align="char" char="." colspan="1" rowspan="1">4.47</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">
Unknown<break></break>
Significance
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="acn3551-note-0003">
<p>CNV, copy number variation; OMIM, Online Mendelian Inheritance in Man; CP, cerebral palsy; dupX, duplicate X chromosome; AR, autosomal recessive; EIEE, early infantile epileptic encephalopathy; NA, not applicable.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
</sec>
<sec id="acn3551-sec-0017">
<title>cDNA analysis</title>
<p>We identified two splicing candidate variants (<italic>CTNNB1</italic>, Chr3: 41275790 T &gt; C and <italic>AMPD2</italic>, Chr1: 110168415 G &gt; A) in case 3 and case 11, respectively. We explored the effect of these variants on mRNA transcription using reverse transcription polymerase chain reaction (RT‐PCR). We obtained each wild‐type transcript and aberrant transcripts (Fig. <xref ref-type="fig" rid="acn3551-fig-0004">4</xref>). Sequence analysis of these cDNAs showed that translation of each aberrant transcript would have catenin beta‐1 and AMP deaminase 2 prematurely terminated. The variant in case 3 of <italic>CTNNB1</italic> resulted in a frameshift followed by a premature termination at codon 572 of the mutant protein, which was preceded by an abnormal sequence of 10 amino acids (p.Glu562AlafsTer11) (Fig. <xref ref-type="fig" rid="acn3551-fig-0004">4</xref>A and B). Another variant in case 11 of <italic>AMPD2</italic> also resulted in a premature termination at codon 216, which is the position immediately after the variant (Fig. <xref ref-type="fig" rid="acn3551-fig-0004">4</xref>C and D). These results support the pathogenicity of each variant.</p>
<fig fig-type="Figure" id="acn3551-fig-0004" orientation="portrait" position="float" xml:lang="en">
<label>Figure 4</label>
<caption>
<p>Analysis of the splice‐site variant of <italic><styled-content style="fixed-case">CTNNB</styled-content>1</italic> in case 3 and <italic><styled-content style="fixed-case">AMPD</styled-content>2</italic> in case 11. (A) <styled-content style="fixed-case">RT</styled-content>‐<styled-content style="fixed-case">PCR</styled-content> product of partial <italic><styled-content style="fixed-case">CTNNB</styled-content>1</italic> run on 2% agarose gel electrophoresis. <styled-content style="fixed-case">RT</styled-content>‐<styled-content style="fixed-case">PCR</styled-content> products obtained from <styled-content style="fixed-case">RNA</styled-content> of peripheral blood lymphocytes. (B) <italic><styled-content style="fixed-case">CTNNB</styled-content>1</italic> sequence analysis of <styled-content style="fixed-case">cDNA</styled-content>. The locations and corresponding <styled-content style="fixed-case">cDNA</styled-content> sequencing results focusing on the exon 10–11 junction in the wild‐type (top) and <italic><styled-content style="fixed-case">CTNNB</styled-content>1</italic> mutant <styled-content style="fixed-case">cDNA</styled-content> (bottom) obtained from <styled-content style="fixed-case">RT</styled-content>‐<styled-content style="fixed-case">PCR</styled-content>. The corresponding translated amino acid sequences for the actual and hypothetical mutant products are also shown. The locations of the variants and stop codons are marked in the mutant diagram. (C) <styled-content style="fixed-case">RT</styled-content>‐<styled-content style="fixed-case">PCR</styled-content> product of partial <italic><styled-content style="fixed-case">AMPD</styled-content>2</italic> from electrophoresis. (D) <italic><styled-content style="fixed-case">AMPD</styled-content>2</italic> sequence analysis of <styled-content style="fixed-case">cDNA</styled-content>. The locations and corresponding <styled-content style="fixed-case">cDNA</styled-content> sequencing results focusing on the exon 4–5 junction in the wild‐type (top) and <italic><styled-content style="fixed-case">AMPD</styled-content>2</italic> mutant <styled-content style="fixed-case">cDNA</styled-content> (bottom) obtained from <styled-content style="fixed-case">RT</styled-content>‐<styled-content style="fixed-case">PCR</styled-content>. The corresponding translated amino acid sequences for the actual and hypothetical mutant products are also shown. The locations of the variant and stop codons are marked in the mutant diagram. bp, base pair; <styled-content style="fixed-case">MW</styled-content>, molecular weight; <styled-content style="fixed-case">NC</styled-content>, negative control; Ctr, control.</p>
</caption>
<graphic id="nlm-graphic-7" xlink:href="ACN3-5-538-g004"></graphic>
</fig>
</sec>
<sec id="acn3551-sec-0018">
<title>AMP deaminase assay</title>
<p>
<italic>AMPD2</italic> encodes one of three known AMP deaminase homologues, which convert AMP to IMP, and is necessary for guanine nucleotide biosynthesis and protein translation.<xref ref-type="ref" rid="acn3551-bib-0026">26</xref> To validate the pathogenicity of <italic>AMPD2</italic> compound heterozygous variants in case 11, we performed an AMP deaminase activity assay. We found a significant reduction in AMP deaminase activity by approximately 60% in EBV‐LCL case 11 compared to two healthy controls and case 3 (Fig. <xref ref-type="fig" rid="acn3551-fig-0005">5</xref>A and B).</p>
<fig fig-type="Figure" id="acn3551-fig-0005" orientation="portrait" position="float" xml:lang="en">
<label>Figure 5</label>
<caption>
<p>
<styled-content style="fixed-case">AMP</styled-content> deaminase assay. (A) Blue intensity represents relative activity. <styled-content style="fixed-case">NC</styled-content>, Negative control; Ctr, Control. (B) Quantification of relative absorbance ± <styled-content style="fixed-case">SD</styled-content> for six independent experiments measured at 625 nm. *<italic>P</italic> &lt; 0.001. a Dunnett's test for unequal variance.</p>
</caption>
<graphic id="nlm-graphic-9" xlink:href="ACN3-5-538-g005"></graphic>
</fig>
</sec>
</sec>
<sec id="acn3551-sec-0019">
<title>Discussion</title>
<p>A comprehensive genomic analysis by aCGH and trio WES was performed in 17 unexplained CP patients without a history of preterm delivery or specific MRI findings. We found that nine patients (52.9%) had pathogenic/likely pathogenic variants according to the ACMG guidelines and that these variants were de novo in seven patients and recessively inherited in two patients. The gene identified in eight CP masqueraders consisted of three hereditary spastic paraplegia (HSP) genes (<italic>CYP2U1</italic>,<italic> SPAST</italic>, and <italic>AMPD2</italic>), four genes associated with early infantile epileptic encephalopathy (EIEE) and neurodevelopmental diseases (<italic>SCN2A</italic>,<italic> CACNA1A</italic>,<italic> GNAO1</italic>, and <italic>STXBP1</italic>) and one other gene (<italic>CTNNB1</italic>). We confirmed the pathogenicity of two splice‐site variants in <italic>AMPD2</italic> and <italic>CTNNB1</italic> and one missense variant in <italic>AMPD2</italic> using in vitro functional analysis. In a previous report, candidate variants were identified in 14 of 98 unselected CP patients (14.3%),<xref ref-type="ref" rid="acn3551-bib-0002">2</xref> indicating that our detection rate was significantly higher (<italic>P</italic> &lt; 0.005, Fisher's exact test). Furthermore, if the variants of the previous study had been prioritized according to the ACMG guidelines and only genes known to be relevant to neurodevelopmental disorders were retained, the detection rate of candidate pathogenic/likely pathogenic genes for CP would have decreased to 4% (4 in 98 patients), contributing to an even larger difference compared to our study. Therefore, full‐term CP includes more masqueraders than the general population of CP patients, which suggests that efficient genetic testing can be developed for full‐term CP patients using trio WES analysis. Moreover, similar result have been reported by a recent study, according to which 11 of 78 patients with neurodevelopmental disorders diagnosed using WES exhibited CP‐like syndrome.<xref ref-type="ref" rid="acn3551-bib-0035">35</xref>
</p>
<p>No significant pathogenic CNVs were identified with aCGH in this study, unlike other previous reports,<xref ref-type="ref" rid="acn3551-bib-0003">3</xref>, <xref ref-type="ref" rid="acn3551-bib-0036">36</xref> in which pathogenic CNVs were identified in 9.6–31% of patients with aCGH. This wide range of proportions could be explained by variations in case selection or differences in the criteria used to evaluate pathogenicity. A high rate of pathologic CNVs (16%) was reported in children who were born small for their gestational age (SGA) with a persistent short stature.<xref ref-type="ref" rid="acn3551-bib-0037">37</xref> SGA patients enrolled in the previous CP cohorts may have contributed to the higher detection rate of CNVs compared to our CP cohorts, which contained only one SGA patient. Our findings indicate that the diagnostic yield of aCGH may be low in full‐term CP; however, further research with a larger sample is needed for establishing recommendations for the diagnostic testing strategy.</p>
<p>We identified candidate pathogenic variants of three genes known to cause HSP in four patients (<italic>CYP2U1</italic> in case 5; <italic>SPAST</italic> in cases 6 and 10; and <italic>AMPD2</italic> in case 11). HSP is a heterogeneous neurological disorder characterized by progressive spasticity and weakness of the lower limbs.<xref ref-type="ref" rid="acn3551-bib-0038">38</xref> To date, 55 HSP genes have been identified. HSP is clinically classified as either the pure form or complicated form, the latter of which is associated with additional neurological features such as ataxia, intellectual disability, neuropathy, and epilepsy.<xref ref-type="ref" rid="acn3551-bib-0038">38</xref> Present cases (case 5, 6, 10, and 11) all showed nonprogressive spastic diplegia during an extended follow‐up period (range, 51–260 months), which is consistent with criteria for CP but not HSP.<xref ref-type="ref" rid="acn3551-bib-0001">1</xref>, <xref ref-type="ref" rid="acn3551-bib-0038">38</xref> This suggests that these HSP genes can cause not only HSP, but also the spastic type of CP masqueraders. A homozygous nonsense variant was identified in case 5 in <italic>CYP2U1</italic>, which was reported to cause SPG56.<xref ref-type="ref" rid="acn3551-bib-0038">38</xref> Symptoms of case 5 included intellectual disability and spastic diplegia, which resembled the phenotype of SPG56.<xref ref-type="ref" rid="acn3551-bib-0038">38</xref> In cases 6 and 10, we found two known de novo variants in <italic>SPAST</italic>,<xref ref-type="ref" rid="acn3551-bib-0027">27</xref>, <xref ref-type="ref" rid="acn3551-bib-0028">28</xref> which is the most commonly mutated gene (SPG4) in HSP.<xref ref-type="ref" rid="acn3551-bib-0037">37</xref> Cases 6 and 10 developed a mild form of spastic diplegia, which was consistent with the severity of other patients who had variants in <italic>SPAST</italic>. Case 11 had compound heterozygous variants and low deaminase activity in her EBV‐LCL cells. A frameshift <italic>AMPD2</italic> variant was recently identified in a patient with complicated HSP,<xref ref-type="ref" rid="acn3551-bib-0039">39</xref> whereas <italic>AMPD2</italic> variants were mainly reported in pontocerebellar hypoplasia.<xref ref-type="ref" rid="acn3551-bib-0026">26</xref> Our results, together with a previous report, extend the phenotypic spectrum of <italic>AMPD2</italic> variants (see Appendix <xref ref-type="supplementary-material" rid="acn3551-sup-0002">S1</xref>).</p>
<p>Four candidate pathogenic/likely pathogenic variants of genes for EIEE and neurodevelopmental diseases were identified in four patients, including <italic>GNAO1</italic> in case 7, <italic>CACNA1A</italic> in case 9, <italic>STXBP1</italic> in case 12, and <italic>SCN2A</italic> in case 17. <italic>GNAO1</italic> variants cause both EIEE and neurodevelopmental disorders,<xref ref-type="ref" rid="acn3551-bib-0029">29</xref> which manifested in case 7 as an intellectual disability, although no seizures occurred. We identified p.(Ser218Leu) variants in case 9, diagnosed as ataxic CP. The p.Phe1502del variant of <italic>CACNA1A</italic> has been reported to cause congenital ataxia, which has similar characteristics to case 9.<xref ref-type="ref" rid="acn3551-bib-0040">40</xref>
<italic>CACNA1A</italic> variants cause various neuropsychiatric diseases. The p.(Ser218Leu) variant has also been associated with familial hemiplegic migraines and cerebellar ataxia,<xref ref-type="ref" rid="acn3551-bib-0030">30</xref> as well as EIEE.<xref ref-type="ref" rid="acn3551-bib-0031">31</xref> If the cerebellar ataxia develops congenitally and appears stable, it may be due to ataxic CP masqueraders, as in case 9. <italic>STXBP1</italic> has been primarily reported to be a causative gene for EIEE. Additionally, various phenotypic features were recently described, including autistic features, spasticity, hypotonia, ataxia, and dyskinesia. Because approximately 5% of patients with variants of <italic>STXBP1</italic> do not have seizures and a patient with the same variant as that in case 12 has been reported to show similar phenotypic symptoms, including ataxia, wide‐based gait, intention tremor, and intellectual disability without epilepsy,<xref ref-type="ref" rid="acn3551-bib-0032">32</xref> it is likely that candidate variant in <italic>STXBP1</italic> caused ataxic CP with such phenotype in case 12. Some patients with <italic>SCN2A</italic> variants show intellectual disability, autistic behaviors, involuntary movement, and lower limb spasticity in addition to epilepsy,<xref ref-type="ref" rid="acn3551-bib-0041">41</xref> which explains the symptoms of case 17. Furthermore, case 17 was also a compound heterozygote of <italic>SPTBN2</italic> variants. <italic>SPTBN2</italic> has been identified in both autosomal dominant and autosomal recessive spinocerebellar ataxia,<xref ref-type="ref" rid="acn3551-bib-0042">42</xref> together with CP.<xref ref-type="ref" rid="acn3551-bib-0034">34</xref> Although both <italic>SPTBN2</italic> variants in case 17 were classified as having uncertain significance and the patient's clinical presentation was consistent with <italic>SCN2A</italic>‐related disorder, we cannot eliminate the possibility that those variants in <italic>SPTNBN2</italic> could contribute to the patient's phenotype. In addition to genes for HSP and EIEE/neurodevelopmental disorders, we identified a variant of <italic>CTNNB1</italic> in case 3. Although the variants of <italic>CTNNB1</italic> have been reported to cause autosomal dominant mental retardation type 19, most of the patients with this variant show signs of other clinical features, including progressive spastic diplegia, hypotonia, microcephaly, craniofacial abnormalities, and hyperekplexia.<xref ref-type="ref" rid="acn3551-bib-0043">43</xref> Case 3 had intellectual disability and spastic diplegia with hyperekplexia, which corresponded with the phenotype for <italic>CTNNB1</italic>‐related diseases.</p>
<p>Although the phenotypes are quite similar to CP, six of the eight genes identified as having candidate pathogenic/likely pathogenic variants (<italic>CTNNB1</italic>,<italic> CYP2U1</italic>,<italic> GNAO1</italic>,<italic> CACNA1A</italic>,<italic> AMPD2</italic>, and <italic>SCN2A</italic>) have not been reported to be the causative genes of CP potentially because they do not fit the definition of CP, such as the presence of regression or an older age onset. Therefore, these gene variants may be found in a wide clinical spectrum of neurodevelopmental diseases, such as HSP, complicated forms of intellectual disability, EIEE, and CP masqueraders.</p>
<p>The identification of the causative genes may affect patient management. For example, deep brain stimulation has been reported to have successfully improved movement disorder in two siblings with the <italic>GNAO1</italic> variant.<xref ref-type="ref" rid="acn3551-bib-0044">44</xref> In addition to the case report, the patient of case 7 can be treated using deep brain stimulation. Moreover, spinocerebellar ataxia type 6, caused by the same causative gene (<italic>CACNA1A</italic>) as that in case 9, could be potentially treated using the miRNA‐mediated therapy in the future, as was reported in the mouse model.<xref ref-type="ref" rid="acn3551-bib-0045">45</xref>
</p>
<p>There are certain limitations of this study. First, the sample size was small in this highly selected case series. Although the yield in this study was significantly higher than that reported in unselected CP patients,<xref ref-type="ref" rid="acn3551-bib-0002">2</xref> our interpretation is limited because no comparison was made with the general CP population. As recent studies have not reported information on gestational ages or brain MRI of patients,<xref ref-type="ref" rid="acn3551-bib-0002">2</xref> we were not able to find CP patients who met our criteria to calculate a diagnostic yield for comparison with our results. Second, there are some gaps between the CP phenotype in this case series and that identified in their variants or genes. Functional validations were not performed in all known or pathogenic/likely pathogenic variants identified in this study. Moreover, functional experiments in the animal model and the identification of other patients with the same phenotype and gene are necessary to confirm our results. A lack of such validation leaves the possibility that those gene variants are not a monogenic cause, rather a contributor to the multifactorial disease, although these variants were prioritized following the ACMG guidelines. Third, the small sample size in our cohort also limited statistical comparisons between the genetic and clinical findings, including CP subtypes and intellectual disability. In terms of CP subtypes, four of the six patients with spasticity contained the variants in genes (<italic>CYP2U1</italic>,<italic> SPAST</italic>, and <italic>AMPD2</italic>) known to cause spastic paraplegia, while the other two contained the variants in genes (<italic>CTNNB1</italic> and <italic>SCN2A</italic>) known to cause other neurodevelopmental disorders. Both genes have not been reported to cause spastic CP; however, the spasticity of patients has been reported previously.<xref ref-type="ref" rid="acn3551-bib-0032">32</xref>, <xref ref-type="ref" rid="acn3551-bib-0041">41</xref> The patients with other CP subtypes, including ataxic type and dyskinetic type, showed no tendency toward spastic diplegia. With respect to intellectual disability, the morbidity was higher (16/17, 94.1%) than previously reported (77.5%),<xref ref-type="ref" rid="acn3551-bib-0046">46</xref> suggesting a representative feature of our cohort, although it is challenging to accurately measure the intellectual disability,<xref ref-type="ref" rid="acn3551-bib-0047">47</xref> and this margin is insignificant owing to the small sample size. Larger CP cohort analyses including full‐term and preterm infants with diverse datasets (e.g., the Apgar score) classified using the brain MRI findings (normal to extensive abnormality, such as PVL) are needed to clarify the genetic epidemiology of CP and CP masqueraders.</p>
<p>In summary, our study showed the possibility that a subset of CP patients categorized by two simple criteria include CP masqueraders despite several limitations. Further genetic investigations of larger cohorts of CP patients are required to help support our results or identify other CP subsets that may likely include masqueraders. This could eventually aid the further characterization of the molecular mechanisms of CP and clinically similar disorders.</p>
</sec>
<sec id="acn3551-sec-0021">
<title>Author Contributions</title>
<p>Y.T., A.K., K.H., Y. N.‐U., Y.K., A.O., and S.K. conceived and designed the study. Y.T., A.K., K.H., Y.N.‐U., T.I., S.S.‐Y., T.M., M.A., S.S.‐M., Y.O., W.E., N.T., and Y.K. recruited patients and collected clinical information and samples. Y.T. and A.K. performed in vitro experiments and array comparative genome hybridization. Y.T., A.K., T.N., R.F., M.S., K.N., and Y.A. performed whole‐exome sequencing and analyzed the data. Y.T., A.K., K.H., and S.K. drafted the manuscript and figures. All authors critically evaluated the manuscript and approved the final version of the manuscript.</p>
</sec>
<sec id="acn3551-sec-0022">
<title>Conflict of Interest</title>
<p>Nothing to report.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material content-type="local-data" id="acn3551-sup-0001">
<caption>
<p>
<bold>Table S1.</bold> Rare variants.</p>
</caption>
<media xlink:href="ACN3-5-538-s001.xlsx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="acn3551-sup-0002">
<caption>
<p>
<bold>Appendix S1.</bold> Case descriptions.</p>
<p>
<bold>Table S2.</bold> The primers used for Sanger sequencing.</p>
</caption>
<media xlink:href="ACN3-5-538-s002.doc">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
</body>
<back>
<ack id="acn3551-sec-0020">
<title>Acknowledgments</title>
<p>The authors thank the patients, families, and doctors who participated in this study. We thank Yoko Chiba, Kumi Ito, Miyuki Tsuda, Mami Kikuchi, Makiko Nakagawa, Yoko Tateda, and Kiyotaka Kuroda for technical assistance. We also acknowledge the support from the Biomedical Research Core of Tohoku University Graduate School of Medicine and Biomedical Research Unit of Tohoku University Hospital. This work was supported by JSPS KAKENHI Grant Number JP16K09983 (to AK and KH) and a research grant for Initiative on Rare and Undiagnosed Diseases in Pediatrics (IRUD‐P) from Japan Agency for Medical Research and Development.</p>
</ack>
<ref-list content-type="cited-references" id="acn3551-bibl-0001">
<title>References</title>
<ref id="acn3551-bib-0001">
<label>1</label>
<mixed-citation id="acn3551-cit-0001" publication-type="journal">
<string-name>
<surname>Rosenbaum</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Paneth</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Leviton</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>A report: the definition and classification of cerebral palsy April 2006</article-title>. <source/>Dev Med Child Neurol Suppl
<year>2007</year>;<volume>109</volume>:<fpage>8</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="pmid">17370477</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0002">
<label>2</label>
<mixed-citation id="acn3551-cit-0002" publication-type="journal">
<string-name>
<surname>McMichael</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Bainbridge</surname>
<given-names>MN</given-names>
</string-name>, <string-name>
<surname>Haan</surname>
<given-names>E</given-names>
</string-name>, et al. <article-title>Whole‐exome sequencing points to considerable genetic heterogeneity of cerebral palsy</article-title>. <source/>Mol Psych
<year>2015</year>;<volume>20</volume>:<fpage>176</fpage>–<lpage>182</lpage>.</mixed-citation>
</ref>
<ref id="acn3551-bib-0003">
<label>3</label>
<mixed-citation id="acn3551-cit-0003" publication-type="journal">
<string-name>
<surname>Oskoui</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Gazzellone</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Thiruvahindrapuram</surname>
<given-names>B</given-names>
</string-name>, et al. <article-title>Clinically relevant copy number variations detected in cerebral palsy</article-title>. <source/>Nat Commun
<year>2015</year>;<volume>6</volume>:<fpage>7949</fpage>.<pub-id pub-id-type="pmid">26236009</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0004">
<label>4</label>
<mixed-citation id="acn3551-cit-0004" publication-type="journal">
<string-name>
<surname>MacLennan</surname>
<given-names>AH</given-names>
</string-name>, <string-name>
<surname>Thompson</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Gecz</surname>
<given-names>J</given-names>
</string-name>. <article-title>Cerebral palsy: causes, pathways, and the role of genetic variants</article-title>. <source/>Am J Obstet Gynecol
<year>2015</year>;<volume>213</volume>:<fpage>779</fpage>–<lpage>788</lpage>.<pub-id pub-id-type="pmid">26003063</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0005">
<label>5</label>
<mixed-citation id="acn3551-cit-0005" publication-type="journal">
<string-name>
<surname>Lee</surname>
<given-names>RW</given-names>
</string-name>, <string-name>
<surname>Poretti</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Cohen</surname>
<given-names>JS</given-names>
</string-name>, et al. <article-title>A diagnostic approach for cerebral palsy in the genomic era</article-title>. <source/>Neuromolecular Med
<year>2014</year>;<volume>16</volume>:<fpage>821</fpage>–<lpage>844</lpage>.<pub-id pub-id-type="pmid">25280894</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0006">
<label>6</label>
<mixed-citation id="acn3551-cit-0006" publication-type="journal">
<string-name>
<surname>Oskoui</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Coutinho</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Dykeman</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>An update on the prevalence of cerebral palsy: a systematic review and meta‐analysis</article-title>. <source/>Dev Med Child Neurol
<year>2013</year>;<volume>55</volume>:<fpage>509</fpage>–<lpage>519</lpage>.<pub-id pub-id-type="pmid">23346889</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0007">
<label>7</label>
<mixed-citation id="acn3551-cit-0007" publication-type="journal">
<string-name>
<surname>Gould</surname>
<given-names>DB</given-names>
</string-name>, <string-name>
<surname>Phalan</surname>
<given-names>FC</given-names>
</string-name>, <string-name>
<surname>Breedveld</surname>
<given-names>GJ</given-names>
</string-name>, et al. <article-title>Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly</article-title>. <source/>Science
<year>2005</year>;<volume>308</volume>:<fpage>1167</fpage>–<lpage>1171</lpage>.<pub-id pub-id-type="pmid">15905400</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0008">
<label>8</label>
<mixed-citation id="acn3551-cit-0008" publication-type="journal">
<string-name>
<surname>Cardo</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Campistol</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Caritg</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Fatal haemorrhagic infarct in an infant with homocystinuria</article-title>. <source/>Dev Med Child Neurol
<year>1999</year>;<volume>41</volume>:<fpage>132</fpage>–<lpage>135</lpage>.<pub-id pub-id-type="pmid">10075100</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0009">
<label>9</label>
<mixed-citation id="acn3551-cit-0009" publication-type="journal">
<string-name>
<surname>Numata</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Onuma</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kobayashi</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>Brain magnetic resonance imaging and motor and intellectual functioning in 86 patients born at term with spastic diplegia</article-title>. <source/>Dev Med Child Neurol
<year>2013</year>;<volume>55</volume>:<fpage>167</fpage>–<lpage>172</lpage>.<pub-id pub-id-type="pmid">23121133</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0010">
<label>10</label>
<mixed-citation id="acn3551-cit-0010" publication-type="journal">
<string-name>
<surname>Palisano</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Rosenbaum</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Bartlett</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Livingston</surname>
<given-names>MH</given-names>
</string-name>. <article-title>Content validity of the expanded and revised gross motor function classification system</article-title>. <source/>Dev Med Child Neurol
<year>2008</year>;<volume>50</volume>:<fpage>744</fpage>–<lpage>750</lpage>.<pub-id pub-id-type="pmid">18834387</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0011">
<label>11</label>
<mixed-citation id="acn3551-cit-0011" publication-type="journal">
<string-name>
<surname>Eliasson</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Krumlinde‐Sundholm</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Rosblad</surname>
<given-names>B</given-names>
</string-name>, et al. <article-title>The Manual Ability Classification System (MACS) for children with cerebral palsy: scale development and evidence of validity and reliability</article-title>. <source/>Dev Med Child Neurol
<year>2006</year>;<volume>48</volume>:<fpage>549</fpage>–<lpage>554</lpage>.<pub-id pub-id-type="pmid">16780622</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0012">
<label>12</label>
<mixed-citation id="acn3551-cit-0012" publication-type="journal">
<string-name>
<surname>Hidecker</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Paneth</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Rosenbaum</surname>
<given-names>PL</given-names>
</string-name>, et al. <article-title>Developing and validating the communication function classification system for individuals with cerebral palsy</article-title>. <source/>Dev Med Child Neurol
<year>2011</year>;<volume>53</volume>:<fpage>704</fpage>–<lpage>710</lpage>.<pub-id pub-id-type="pmid">21707596</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0013">
<label>13</label>
<mixed-citation id="acn3551-cit-0013" publication-type="journal">
<string-name>
<surname>Christine</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Dolk</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Platt</surname>
<given-names>MJ</given-names>
</string-name>, et al. <article-title>Recommendations from the SCPE collaborative group for defining and classifying cerebral palsy</article-title>. <source/>Dev Med Child Neurol Suppl
<year>2007</year>;<volume>109</volume>:<fpage>35</fpage>–<lpage>38</lpage>.<pub-id pub-id-type="pmid">17370480</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0014">
<label>14</label>
<mixed-citation id="acn3551-cit-0014" publication-type="journal">
<string-name>
<surname>MacDonald</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Ziman</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Yuen</surname>
<given-names>RK</given-names>
</string-name>, et al. <article-title>The database of genomic variants: a curated collection of structural variation in the human genome</article-title>. <source/>Nucleic Acids Res
<year>2014</year>;<volume>42</volume>:<fpage>D986</fpage>–<lpage>D992</lpage>.<pub-id pub-id-type="pmid">24174537</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0015">
<label>15</label>
<mixed-citation id="acn3551-cit-0015" publication-type="journal">
<string-name>
<surname>Li</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Durbin</surname>
<given-names>R</given-names>
</string-name>. <article-title>Fast and accurate short read alignment with Burrows‐Wheeler transform</article-title>. <source/>Bioinformatics
<year>2009</year>;<volume>25</volume>:<fpage>1754</fpage>–<lpage>1760</lpage>.<pub-id pub-id-type="pmid">19451168</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0016">
<label>16</label>
<mixed-citation id="acn3551-cit-0016" publication-type="journal">
<string-name>
<surname>McKenna</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hanna</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Banks</surname>
<given-names>E</given-names>
</string-name>, et al. <article-title>The genome analysis toolkit: a MapReduce framework for analyzing next‐generation DNA sequencing data</article-title>. <source/>Genome Res
<year>2010</year>;<volume>20</volume>:<fpage>1297</fpage>–<lpage>1303</lpage>.<pub-id pub-id-type="pmid">20644199</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0017">
<label>17</label>
<mixed-citation id="acn3551-cit-0017" publication-type="journal">
<string-name>
<surname>Wang</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hakonarson</surname>
<given-names>H</given-names>
</string-name>. <article-title>ANNOVAR: functional annotation of genetic variants from high‐throughput sequencing data</article-title>. <source/>Nucleic Acids Res
<year>2010</year>;<volume>38</volume>:<fpage>e164</fpage>.<pub-id pub-id-type="pmid">20601685</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0018">
<label>18</label>
<mixed-citation id="acn3551-cit-0018" publication-type="journal">
<string-name>
<surname>Narahara</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Higasa</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Nakamura</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Large‐scale East‐Asian eQTL mapping reveals novel candidate genes for LD mapping and the genomic landscape of transcriptional effects of sequence variants</article-title>. <source/>PLoS One
<year>2014</year>;<volume>9</volume>:<fpage>e100924</fpage>.<pub-id pub-id-type="pmid">24956270</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0019">
<label>19</label>
<mixed-citation id="acn3551-cit-0019" publication-type="journal">
<string-name>
<surname>Higasa</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Miyake</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Yoshimura</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Human genetic variation database, a reference database of genetic variations in the Japanese population</article-title>. <source/>J Hum Genet
<year>2016</year>;<volume>61</volume>:<fpage>547</fpage>–<lpage>553</lpage>.<pub-id pub-id-type="pmid">26911352</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0020">
<label>20</label>
<mixed-citation id="acn3551-cit-0020" publication-type="journal">
<string-name>
<surname>Ng</surname>
<given-names>PC</given-names>
</string-name>, <string-name>
<surname>Henikoff</surname>
<given-names>S</given-names>
</string-name>. <article-title>SIFT: predicting amino acid changes that affect protein function</article-title>. <source/>Nucleic Acids Res
<year>2003</year>;<volume>31</volume>:<fpage>3812</fpage>–<lpage>3814</lpage>.<pub-id pub-id-type="pmid">12824425</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0021">
<label>21</label>
<mixed-citation id="acn3551-cit-0021" publication-type="journal">
<string-name>
<surname>Adzhubei</surname>
<given-names>IA</given-names>
</string-name>, <string-name>
<surname>Schmidt</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Peshkin</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>A method and server for predicting damaging missense mutations</article-title>. <source/>Nat Methods
<year>2010</year>;<volume>7</volume>:<fpage>248</fpage>–<lpage>249</lpage>.<pub-id pub-id-type="pmid">20354512</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0022">
<label>22</label>
<mixed-citation id="acn3551-cit-0022" publication-type="journal">
<string-name>
<surname>Cooper</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Goode</surname>
<given-names>DL</given-names>
</string-name>, <string-name>
<surname>Ng</surname>
<given-names>SB</given-names>
</string-name>, et al. <article-title>Single‐nucleotide evolutionary constraint scores highlight disease‐causing mutations</article-title>. <source/>Nat Methods
<year>2010</year>;<volume>7</volume>:<fpage>250</fpage>–<lpage>251</lpage>.<pub-id pub-id-type="pmid">20354513</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0023">
<label>23</label>
<mixed-citation id="acn3551-cit-0023" publication-type="journal">
<string-name>
<surname>Kircher</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Witten</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Jain</surname>
<given-names>P</given-names>
</string-name>, et al. <article-title>A general framework for estimating the relative pathogenicity of human genetic variants</article-title>. <source/>Nat Genet
<year>2014</year>;<volume>46</volume>:<fpage>310</fpage>–<lpage>315</lpage>.<pub-id pub-id-type="pmid">24487276</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0024">
<label>24</label>
<mixed-citation id="acn3551-cit-0024" publication-type="journal">
<string-name>
<surname>Richards</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Aziz</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Bale</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology</article-title>. <source/>Genet Med
<year>2015</year>;<volume>17</volume>:<fpage>405</fpage>–<lpage>424</lpage>.<pub-id pub-id-type="pmid">25741868</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0025">
<label>25</label>
<mixed-citation id="acn3551-cit-0025" publication-type="journal">
<string-name>
<surname>Hui‐Yuen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>McAllister</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Koganti</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Establishment of Epstein‐Barr virus growth‐transformed lymphoblastoid cell lines</article-title>. <source/>J Vis Exp
<year>2011</year>;<volume>57</volume>:<fpage>e3321</fpage>.</mixed-citation>
</ref>
<ref id="acn3551-bib-0026">
<label>26</label>
<mixed-citation id="acn3551-cit-0026" publication-type="journal">
<string-name>
<surname>Akizu</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Cantagrel</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Schroth</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>AMPD2 regulates GTP synthesis and is mutated in a potentially treatable neurodegenerative brainstem disorder</article-title>. <source/>Cell
<year>2013</year>;<volume>154</volume>:<fpage>505</fpage>–<lpage>517</lpage>.<pub-id pub-id-type="pmid">23911318</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0027">
<label>27</label>
<mixed-citation id="acn3551-cit-0027" publication-type="journal">
<string-name>
<surname>Braschinsky</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tamm</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Beetz</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Unique spectrum of SPAST variants in Estonian HSP patients: presence of benign missense changes but lack of exonic rearrangements</article-title>. <source/>BMC Neurol
<year>2010</year>;<volume>10</volume>:<fpage>17</fpage>.<pub-id pub-id-type="pmid">20214791</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0028">
<label>28</label>
<mixed-citation id="acn3551-cit-0028" publication-type="journal">
<string-name>
<surname>Crippa</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Panzeri</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Martinuzzi</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Eight novel mutations in SPG4 in a large sample of patients with hereditary spastic paraplegia</article-title>. <source/>Arch Neurol
<year>2006</year>;<volume>63</volume>:<fpage>750</fpage>–<lpage>755</lpage>.<pub-id pub-id-type="pmid">16682546</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0029">
<label>29</label>
<mixed-citation id="acn3551-cit-0029" publication-type="journal">
<string-name>
<surname>Saitsu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Fukai</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Ben‐Zeev</surname>
<given-names>B</given-names>
</string-name>, et al. <article-title>Phenotypic spectrum of GNAO1 variants: epileptic encephalopathy to involuntary movements with severe developmental delay</article-title>. <source/>Eur J Hum Genet
<year>2016</year>;<volume>24</volume>:<fpage>129</fpage>–<lpage>134</lpage>.<pub-id pub-id-type="pmid">25966631</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0030">
<label>30</label>
<mixed-citation id="acn3551-cit-0030" publication-type="journal">
<string-name>
<surname>Kors</surname>
<given-names>EE</given-names>
</string-name>, <string-name>
<surname>Terwindt</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Vermeulen</surname>
<given-names>FL</given-names>
</string-name>, et al. <article-title>Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine</article-title>. <source/>Ann Neurol
<year>2001</year>;<volume>49</volume>:<fpage>753</fpage>–<lpage>760</lpage>.<pub-id pub-id-type="pmid">11409427</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0031">
<label>31</label>
<mixed-citation id="acn3551-cit-0031" publication-type="journal">
<string-name>
<surname>Epi</surname>
<given-names>KC</given-names>
</string-name>; <collab collab-type="authors">Epilepsy Phenome/Genome P</collab>
, <string-name>
<surname>Genome</surname>
<given-names>P</given-names>
</string-name>, et al. <article-title>De novo mutations in epileptic encephalopathies</article-title>. <source/>Nature
<year>2013</year>;<volume>501</volume>:<fpage>217</fpage>–<lpage>221</lpage>.<pub-id pub-id-type="pmid">23934111</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0032">
<label>32</label>
<mixed-citation id="acn3551-cit-0032" publication-type="journal">
<string-name>
<surname>Stamberger</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Nikanorova</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Willemsen</surname>
<given-names>MH</given-names>
</string-name>, et al. <article-title>STXBP1 encephalopathy: a neurodevelopmental disorder including epilepsy</article-title>. <source/>Neurology
<year>2016</year>;<volume>86</volume>:<fpage>954</fpage>–<lpage>962</lpage>.<pub-id pub-id-type="pmid">26865513</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0033">
<label>33</label>
<mixed-citation id="acn3551-cit-0033" publication-type="journal">
<string-name>
<surname>Blair</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Riddle</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Wells</surname>
<given-names>JF</given-names>
</string-name>, et al. <article-title>Infantile onset of hereditary spastic paraplegia poorly predicts the genotype</article-title>. <source/>Pediatr Neurol
<year>2007</year>;<volume>36</volume>:<fpage>382</fpage>–<lpage>386</lpage>.<pub-id pub-id-type="pmid">17560499</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0034">
<label>34</label>
<mixed-citation id="acn3551-cit-0034" publication-type="journal">
<string-name>
<surname>Parolin Schnekenberg</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Perkins</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Miller</surname>
<given-names>JW</given-names>
</string-name>, et al. <article-title>De novo point mutations in patients diagnosed with ataxic cerebral palsy</article-title>. <source/>Brain
<year>2015</year>;<volume>138</volume>:<fpage>1817</fpage>–<lpage>1832</lpage>.<pub-id pub-id-type="pmid">25981959</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0035">
<label>35</label>
<mixed-citation id="acn3551-cit-0035" publication-type="journal">
<string-name>
<surname>Srivastava</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Cohen</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Vernon</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>Clinical whole exome sequencing in child neurology practice</article-title>. <source/>Ann Neurol
<year>2014</year>;<volume>76</volume>:<fpage>473</fpage>–<lpage>483</lpage>.<pub-id pub-id-type="pmid">25131622</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0036">
<label>36</label>
<mixed-citation id="acn3551-cit-0036" publication-type="journal">
<string-name>
<surname>Segel</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Ben‐Pazi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Zeligson</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Copy number variations in cryptogenic cerebral palsy</article-title>. <source/>Neurology
<year>2015</year>;<volume>84</volume>:<fpage>1660</fpage>–<lpage>1668</lpage>.<pub-id pub-id-type="pmid">25817843</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0037">
<label>37</label>
<mixed-citation id="acn3551-cit-0037" publication-type="journal">
<string-name>
<surname>Canton</surname>
<given-names>AP</given-names>
</string-name>, <string-name>
<surname>Costa</surname>
<given-names>SS</given-names>
</string-name>, <string-name>
<surname>Rodrigues</surname>
<given-names>TC</given-names>
</string-name>, et al. <article-title>Genome‐wide screening of copy number variants in children born small for gestational age reveals several candidate genes involved in growth pathways</article-title>. <source/>Eur J Endocrinol
<year>2014</year>;<volume>171</volume>:<fpage>253</fpage>–<lpage>262</lpage>.<pub-id pub-id-type="pmid">24878679</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0038">
<label>38</label>
<mixed-citation id="acn3551-cit-0038" publication-type="journal">
<string-name>
<surname>Lo Giudice</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Lombardi</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Santorelli</surname>
<given-names>FM</given-names>
</string-name>, et al. <article-title>Hereditary spastic paraplegia: clinical‐genetic characteristics and evolving molecular mechanisms</article-title>. <source/>Exp Neurol
<year>2014</year>;<volume>261</volume>:<fpage>518</fpage>–<lpage>539</lpage>.<pub-id pub-id-type="pmid">24954637</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0039">
<label>39</label>
<mixed-citation id="acn3551-cit-0039" publication-type="journal">
<string-name>
<surname>Novarino</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Fenstermaker</surname>
<given-names>AG</given-names>
</string-name>, <string-name>
<surname>Zaki</surname>
<given-names>MS</given-names>
</string-name>, et al. <article-title>Exome sequencing links corticospinal motor neuron disease to common neurodegenerative disorders</article-title>. <source/>Science
<year>2014</year>;<volume>343</volume>:<fpage>506</fpage>–<lpage>511</lpage>.<pub-id pub-id-type="pmid">24482476</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0040">
<label>40</label>
<mixed-citation id="acn3551-cit-0040" publication-type="journal">
<string-name>
<surname>Garcia Segarra</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Gautschi</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Mittaz‐Crettol</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>Congenital ataxia and hemiplegic migraine with cerebral edema associated with a novel gain of function mutation in the calcium channel CACNA1A</article-title>. <source/>J Neurol Sci
<year>2014</year>;<volume>342</volume>:<fpage>69</fpage>–<lpage>78</lpage>.<pub-id pub-id-type="pmid">24836863</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0041">
<label>41</label>
<mixed-citation id="acn3551-cit-0041" publication-type="journal">
<string-name>
<surname>Howell</surname>
<given-names>KB</given-names>
</string-name>, <string-name>
<surname>McMahon</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Carvill</surname>
<given-names>GL</given-names>
</string-name>, et al. <article-title>SCN2A encephalopathy: a major cause of epilepsy of infancy with migrating focal seizures</article-title>. <source/>Neurology
<year>2015</year>;<volume>85</volume>:<fpage>958</fpage>–<lpage>966</lpage>.<pub-id pub-id-type="pmid">26291284</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0042">
<label>42</label>
<mixed-citation id="acn3551-cit-0042" publication-type="journal">
<string-name>
<surname>Ikeda</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Dick</surname>
<given-names>KA</given-names>
</string-name>, <string-name>
<surname>Weatherspoon</surname>
<given-names>MR</given-names>
</string-name>, et al. <article-title>Spectrin mutations cause spinocerebellar ataxia type 5</article-title>. <source/>Nat Genet
<year>2006</year>;<volume>38</volume>:<fpage>184</fpage>–<lpage>190</lpage>.<pub-id pub-id-type="pmid">16429157</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0043">
<label>43</label>
<mixed-citation id="acn3551-cit-0043" publication-type="journal">
<string-name>
<surname>Kuechler</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Willemsen</surname>
<given-names>MH</given-names>
</string-name>, <string-name>
<surname>Albrecht</surname>
<given-names>B</given-names>
</string-name>, et al. <article-title>De novo mutations in beta‐catenin (CTNNB1) appear to be a frequent cause of intellectual disability: expanding the mutational and clinical spectrum</article-title>. <source/>Hum Genet
<year>2015</year>;<volume>134</volume>:<fpage>97</fpage>–<lpage>109</lpage>.<pub-id pub-id-type="pmid">25326669</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0044">
<label>44</label>
<mixed-citation id="acn3551-cit-0044" publication-type="journal">
<string-name>
<surname>Kulkarni</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Bhardwaj</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>Progressive movement disorder in brothers carrying a GNAO1 mutation responsive to deep brain stimulation</article-title>. <source/>J Child Neurol
<year>2016</year>;<volume>31</volume>:<fpage>211</fpage>–<lpage>214</lpage>.<pub-id pub-id-type="pmid">26060304</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0045">
<label>45</label>
<mixed-citation id="acn3551-cit-0045" publication-type="journal">
<string-name>
<surname>Miyazaki</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Du</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Muramatsu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Gomez</surname>
<given-names>CM</given-names>
</string-name>. <article-title>An miRNA‐mediated therapy for SCA6 blocks IRES‐driven translation of the CACNA1A second cistron</article-title>. <source/>Sci Transl Med
<year>2016</year>;<volume>8</volume>:<fpage>347ra94</fpage>.</mixed-citation>
</ref>
<ref id="acn3551-bib-0046">
<label>46</label>
<mixed-citation id="acn3551-cit-0046" publication-type="journal">
<string-name>
<surname>Gabis</surname>
<given-names>LV</given-names>
</string-name>, <string-name>
<surname>Tsubary</surname>
<given-names>NM</given-names>
</string-name>, <string-name>
<surname>Leon</surname>
<given-names>O</given-names>
</string-name>, et al. <article-title>Assessment of abilities and comorbidities in children with cerebral palsy</article-title>. <source/>J Child Neurol
<year>2015</year>;<volume>30</volume>:<fpage>1640</fpage>–<lpage>1645</lpage>.<pub-id pub-id-type="pmid">25855688</pub-id></mixed-citation>
</ref>
<ref id="acn3551-bib-0047">
<label>47</label>
<mixed-citation id="acn3551-cit-0047" publication-type="journal">
<string-name>
<surname>Sherwell</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Reid</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Reddihough</surname>
<given-names>DS</given-names>
</string-name>, et al. <article-title>Measuring intellectual ability in children with cerebral palsy: can we do better?</article-title>
<source/>Res Dev Disabil
<year>2014</year>;<volume>35</volume>:<fpage>2558</fpage>–<lpage>2567</lpage>.<pub-id pub-id-type="pmid">25005064</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>